intivo works by stopping the virus from multiplying and infecting your child . incivo is used to treat hepatitis c infection in adults and adolescents ( 18 years of age and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . the ns3 -- 4a enzyme is a protein produced by the hepatitis c virus . it is produced by recombinant dna technology and is very similar to peginerferon aluminiumfa and ribavir . incovibil is used in adults who have not previously taken an inter
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : if you think any of them may be related to incivo , tell your doctor . if any of those apply to you , tell the doctor or nurse before taking them . if your doctor has told you that you are at an increased risk of experiencing severe side effects 56 if you also take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 mg twice a day ( 6 mg in the morning and 8 mg in a day ). you should take incivo every day , at the same time of the day . this is to avoid the spread of both hepatitis c virus infection and human immunodeficiency virus infection ( hiv infection ). your doctor will prescribe the right dose for you . if you take more incivo than you should if you have taken more tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , tell your doctor straight away . this is usually mild to moderate and will usually disappear after a few days . if your skin rash gets worse , tell the doctor straightaway . the rash may be severe and needs immediate medical attention . other symptoms that may be a sign of a severe skin reaction tell your physician immediately if you develop a skin rash . your doctor may decide to treat your rash with other treatments . a rash may include fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do this to protect the tablets from moisture and light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo produces 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbinbryt contains the active substance daclizumab beta , a monoclonal antibody . what zinbarta is used for zinibryta can be used in adults with multiple sclerosis . it is used as therapy for two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( also known as demyelination ) can lead to relapsing ms , which can be characterised by repeated attacks ( relapses ). symptoms that occur are mainly
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking zin bryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you that you are not suitable for taking any other medicines . herbal supplements tell your pharmacist if you take any medicines , including supplements obtained without a prescription . liver side
your doctor will decide how much zinbryta you need and how often you need to use this medicine . the recommended dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of the zinbasin is 40 mg once daily . your dose may be increased or decreased depending on the results of this blood test . your next dose may need to be delayed or decreased . your blood test will be repeated every three weeks . how to inject yourself zinbuq is given under the skin ( subcutaneously
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects . your doctor may need to change your treatment . serious side effect : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may effect up to 1 in 100 people severe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to store it in the original package . zin bryta syringes / pens may be stored for up to 30 days
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbarryta is a clear to slightly yellow , colourless solution for injecting in a syringe / pen . it is
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and its further accumulation in the body . wilston ' s medicine has been shown to significantly improve the quality of life for patients with wilson '.
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will monitor you during treatment and may adjust the initial treatment if necessary . in addition , other anti - copper agents such as penicillusamine may be used . your symptoms will be monitored during the treatment .
always take the different dose regimens exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 25 mg or 50 mg once a day . your doctor will tell you the dose to take . the dose may be adjusted by your doctor . the usual dose is 1 mg wilzin 50 mg twice a day ( morning dose ). your doctor may increase your dose to 2 mg wilz 25 mg twice daily ( morning and evening dose ). this dose may also be adjusted 1 to 6 times a day for the first week . the doctor will decide the right dose for you . the
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 100 ), not known ( frequency cannot be estimated from the available data ): very common : may affect more than1 in 10 users very rare : may affects lessthan 1 user of 10 ,000 not known : frequency cannot estimate from the reported
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do this as your doctor or pharmacist will tell you when to store wilzin . donot store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule releases 25 mg ( equivalent of 167 . 84 mg of oz zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e133 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg " on one side
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , ask your doctor for advice . if you have taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking b
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements and vitamins such as magnesium and iron . see section 2 " important information about these medicines ". if you take more biktarvy than you should if you accidentally take too many tablets , contact your doctor immediately . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms are usually mild and of a low severity . if the body ' s immune response is not working normally , it may fight infections with no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are common . medicines given to treat hiv illness can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the bottle immediately after opening . do away with the seal after first opening .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg bic tegravira , 200 mg emtritabine , tenofavir alufenamide fumarate equivalent to 25 mg tenofvir alfaenamide the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , tal
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your body or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started if diet , exercise and weight reduction alone have not been able to control your blood glucose . no vonorm can be used on its own in patients who are already taking metformin for diabetes
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). if 47 you have liver problems . novonors should not be used if you suffer from moderate liver disease , as novonera may not be suitable for you . if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily . the dose may be increased by 4 mg once every 30 minutes for up to 16 weeks . your doctor will monitor your blood sugar regularly and may adjust your dose if necessary . if you take more novonor than you should if you have taken too many tablets , contact your doctor straight
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately . hypoemic reactions are generally mild / moderate . however , hypoglycemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) ( see section 2 " novonor contains lactose "). what novonom looks like and contents of the pack novonorg tablets are white to off - white , round , flat , with " 0
pumarix is a vaccine used in adults ( aged 18 years and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of ovalbumin ( as formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you experience signs of such an allergic react , please contact your doctor immediately . you may require medical treatment . if an allergic response occurs , stop using pumarood and tell your doctor . warnings and precautions 33 talk to your doctor or nurse before using pum
pumarix is for use in adults aged 18 and over . pumarix contains a similar h5n1 as03 to a similar as03 as03 . pumix is not intended for use by children aged 18 years and over , as it is not known if it will be given to you . pumanix is a vaccine for use with children aged 3 - 9 years . puminix is also used in children aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in 100 people ) bruising where the place of thejection has
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after thawing , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the suspension once thawed . do throw away any medicines via wastewater or household waste
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is a component of the pandemic vaccine ( an ' adjuvant ' as03 ). this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumarax looks like
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . it contains gallium (' 68ga ') edotreaotide . this procedure allows the doctor to determine the amount of gallium ' edotreyotide in your body . somakittoc is given into a vein ( part of the body areas ) as a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the use of somak
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if any of these apply to you . allergic reaction is listed in the section 4 possible side effects of somaknittoc . kidney or liver problems if you have renal or hepatic disease if you drink alcohol excessively ( see section 4 for more information ). if you think any of this applies to you , tell your doctor . if you suffer from dehydration , your doctor may decide to reduce the dose of
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep the record of their activities . they are responsible for the correct disposal of radioactivity and for the safe disposal of radioactive materials . they should not use somakitontoc for more than 29 days after the nuclear medicine doctor requested the nuclear medicines doctor requested to supervise the procedure . radiolabelling , somakttoc is given as a single intravenous injection (
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) that have been reported after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the injection will be exposed to ionising radiation ( which is very sensitive to the presence of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaf
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be performed before administration . somakit t will be stored at a concentration of 4 to 25 mbq / m2 . do not freeze . do this to avoid deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg of edotrebotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somaknit t is presented as a radiopharmaceutical preparation in a glass vial with black flip - off cap . it is a white powder supplied
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer ( postmenopausal women ) in women who are treated with non - steroidal aromatase inhibitors ( so - called " serogroups "), which keeps the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid aromATase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours ) in the stomach ,
before cancer treatment with afinitor , tell your doctor if you are taking afincer . if you think you may be allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you suspect you may also be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking afintitor if you have any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afinir . if your doctor has told you that you have diabetes with a high level of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor once daily . if you have liver problems , your doctor may prescribe a lower dose of afginitor . the usual starting dose is 5 mg once daily , but your doctor will adjust the dose to 5 mg or 7 . 5 mg if you experience certain side effects . your doctor can adjust the starting dose of the tablet depending on how you respond to treatment . if necessary , your dose may be increased to a maximum of one tablet once daily depending
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and contact a doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your doctor straight away . the following side effects have been reported with afincer : very common ( may affect more than 1 in 10 people ): increased temperature ( chills ) ( signs of infection ) fever coughing , difficulty breathing , wheezing ( signs for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . the tablets should be used within one week . do this to protect from moisture . do use this product if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each film - coated tablet contains 5 mg of of everlimus . the tablet is available in packs containing 10 tablets of everlonimus .
what laventair ellipta is the active substance of lavent air ellipta . it contains umeclidinium bromide and vilanterol which belong to a group of medicines called bronchodilators . what laventaire ellipta looks like and contents of the pack laventive ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your asthma is getting worse . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : - asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ) - epilepsy - thyroid gland problems -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more laventair ellipta than you should if you have used more lavantair elliptic than you have been told to use , contact your doctor immediately . symptoms of using too much lavent air ellipta include a sudden attack of breathlessness and wheezing . if this attack occurs ,
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may effect up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), becoming very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties are possible .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidiniol ( equivalent to 65 microgram of umephidinol bromides ), 22 microgram s of vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose '), magnesium stearate what laventAir ellipta looks like and contents of the pack laventaire ellipta is an inhalation
tovya contains guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults with moderate to severe " plaque psor psor " an inflammatory condition that affects the skin and nails . tremfya works to improve the condition on the skin , and the appearance of nails . it is used in adults to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and conditions talk to the doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis . you have been in close contact with someone with tuberculosis for 36 years . you think that you may have an infection , but have no symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . you should not inject tremfia more often than once a week . if you inject more tremfyna than you should if you have injected too much tremfella , contact your doctor . if possible , show the doctor your pack of tremfYA . stopping treatment may cause symptoms of psoriasis .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in patients with persistent or recurrent ctph who do not respond adequately to surgical treatment or exercise capacity to reduce symptoms of the disease . chronic throbembolic lung hypertension is when blood pressure is too high , which affects the blood vessels of the
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if your baby has a heart problem . - has had a heart attack ( myocardial infarction ) in the last six months . - have severe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump containing your treprostinil . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per infusion . the infusion rate will be adjusted depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the injection site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after reconstitution . trepulmix may be used for up to 30 days without continuous subcutaneous infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each trepulamix 2 . 5 mg : one vial delivers 2 . 25 mg trestinIL ( asodium salt ). one 10 ml ampoule of 25 ml contains 25 mg of treproprostrinil ( also sodium salt ) . one trepumpulmix 5 mg / 5 ml vials
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) to stop blood clumps from forming in your blood . thorinan is used to prevent blood clops from forming within your blood during treatment with an acute illness called unstable angina . it can also be used to treat a heart attack if blood cl clots are found in your dialysis machine . it may also be given to
do not use thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heperin or to any of your other low molecule weight hepens ( e .. g ., nad
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is given to you to stop the bleeding . if you experience any bleeding event that does not stop as expected , including excessive bleeding ( exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ), you should immediately stop taking your medicine and contact your doctor . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist immediately . if your medicine does not work properly , you may be given thorinANE to treat a severe allergic reaction ( difficulty breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxparin sodium in each pre - filled syringe . each 0 . 2 ml syringe contains 2 , 000 mg of the active substances enoxafarin sodium and water for injections . one pre - fill syringe of 0 . 02 ml contains 2 . 000 mg enoxagarin sodium ( as solvent ). the other ingredients are : powder : water for injection ( see section 2 " thorinan contains sodium "). solvent : colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlor
sensstend contains the active substances lidocaine and prilocaine . it belongs to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which stops the action of ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anahetics ). if your doctor has told you that you have or have had a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) such as anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using this medicine . if you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs ) in each of the following places : 1 . on the head of the penis . 3 sprasters ( 3 spools ) in the following locations : 24 sprays in the same area . 4 sprays per day . how to use remove the spray container from the pump mechanism . gently push down the valve to avoid contact with eyes , nose , mouth and ears . gently pull down the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to 1 in 100 people ) headache local irritation of the throat and irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the part of your penis itching in the space of your erect penis a high temperature other side effects include :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn the container . do this if you notice any particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 50 ml contains 7 . 5 mg lidOCaine and 2 . 5mg prilacaine . - each spray container is 6 . 5 ml . - the other ingredients are 20 micrograms of lidOCain and 20 micrograms of prilOCaine . what senstends looks like and contents of the pack senstension is a clear , colourless to light yellow cut
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment may be surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or you are not able to receive an autologous stem - cell transplant ( a transplant ). advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) when previous therapies had not worked , or
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivos if you : - notice problems with your heart such as a change in the rhythm or the heartbeat becoming irregular . these may be signs of an abnormal heart rhythm . - notice any problems with the airways or breathing difficulties such as cough . - have inflammation of the lungs ( pneumonitis or interstitial lung disease ). - notice diarrhoea , watery , loose or soft stools . - any symptoms of inflammation
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of opdivone is 240 mg once a day ( 2 tablets ) for two consecutive days . this will be given as 480 mg once daily for 4 weeks . your doctor will prescribe the strength that is right for you . your dose of ipilimumab will depend on how you respond to the treatment . for the treatment of skin cancer , the recommended starting dose of opsdivo is 1 mg of nivolumab per kilogram of your body
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 for 48 hours . do away with the infusion solution . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivulumab and 240 mg /ml of solution for injection contains 24 mg of the active substances . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopiderel tAD is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have
do not take clopidogrel tad 30 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel tet . warnings and precautions the following apply to all people taking clapidogl tud : if you think you may be at an increased risk of bleeding if you : have amedical condition that puts you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl to be given orally once at the start of each 75 - day period of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopIDogrel tetad looks like and contents of
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of transplanted organs by the liver and kidneys , and to reduce the effects of any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been taking sirolimus , or any macrolide - like antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). tacrolinus immediate release capsules ( e. g . tacforia prolonged - release capsules ) are not available . tacrolamus prolonged -release capsules are not suitable for children and adolescents . tacfius
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . always take the same tacrolimus medicine as your transplant patient . if you have been given a different tacrolemus medicine , your doctor may tell you to take this other medicine . always check with the doctor or nurse if you think any of the above applies to you . if your doctor thinks you may be taking this medicine , tell your doctor . taking this medication always take this right medicine exactly and check with a
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and tell your doctor immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neut
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . discard all the prolonged - release hard capsules within 1 month of opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforum 0 . 5 mg : each prolonged - release hard capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforiu 1 mg : every prolonged -release hard capsule releases 1 mg of ticrolimas ( asmonohydrate ). each tacforian 3 mg : one prolonged - releasing hard capsule release 3 mg ofTicrolamas (as monohydrate ) each tacnonius 5 mg capsule releases 5 mg of the active substances in each prolonged release hard capsules . the other ingredients are capsule content hypromell
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopiderel zertiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ).
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following apply to some people : if any part of the population is at risk of bleeding ( e . g ., a medicalcondition that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . clopidogrel zentiva may be stored in aluminium blisters for up to 30 days . do this to protect from light . clubidogl zentva should be used in all aluminium blacks . donot use this product if you notice any visible sign of deterioration . do so because it does not require any special
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). see section 2 ' clopiderel zertiva contains lactose ' and ' clogidogl zentva contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacet
yttriga is a radioactive medicine that is stored in a hospital or clinic . it is stored either in a refrigerator ( 2 - 8 ). it is not to be used in combination with another medicine . it must be used together with tiny radiation doses . the treatment with yttrigan is a radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . - if any of these apply to you , tell your doctor before you are given ytriga . - yttrada is a radioactive medicine . - it is not used in combination with another medicinal product . - radiopharmaceuticals are not to be used in this way . - the use of ytiga is not recommended because the radioactive material is not known . - radioactive medicinal products
the treatment should be supervised by a doctor experienced in the diagnosis and treatment of drug addiction . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . yttiga should be administered immediately after preparation . if you are given more yttrada than you should in the event of overdose , your doctor will provide appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances will ensure that any unused product or waste material is disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttrida is a clear , colourless to pale yellow solution in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra in combination with cisplatin , another anti - cancer medicine , is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , when there has not been prior chemotherapy . cinembra in association with cisperatin is used as the initial treatment for patients with advanced stage of lung cancer . your doctor will determine how long you should be treated with ciamBra if you have lung cancer at an advanced stage and if your disease responds to treatment or it remains largely unchanged after initial chemotherapy
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb ( listed in section 6 ) - if breast - feeding is not possible during treatment with ciamba - if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamBra - if any of these apply to you , tell your doctor before using it . - if or during treatment , you may receive a vaccine to prevent yellow fever during treatment . - ciama should not be given to you if you have problems
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust your dose and duration of treatment depending on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last approximately 10 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38Âºc or greater sweating ( common ). infection may occur if you have less white blood cells than normal which is very common . infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ), have a fast heart rate , pain , redness , swelling or sores in your mouth ( common ); allergic reaction ( common ): skin rash ( common , may affect up to 1 in 10 people ), burning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with the vial after reconstitution . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 , 15 or 25 .
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetretted disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient is pemphigus ( as pyrexed dis sodium hemipontahydrated ). after reconstitution , the solution contains 25 mg / ml of pemfigus . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydro
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunoglubulins help to control certain infections in your blood . immunogam may be used to prevent increased levels of human hepatitis b immunoglutulins , immunoglobin g ( ig ) in blood plasma of screened patients . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is a precautionary measure . immunoam works by stopping a hepatitis birus carrier from multiplying , leading to an immune response with a greater number of measurable hepatitis b antibodies . vaccination and continuous
immunogam must not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to iga - derived products . - if an allergic response to igo containing products has occurred . children and adolescents ( aged 18 years and above ) immunogloglobulin have been reported in clinical trials . adverse reactions include chills , headache , fever and vomiting . allergic reactions include nausea ( arthralgia ), joint pain and low blood pressure . moderate low back pain has been reported . antibodies have been developed against hepatitis b immunoglubulin regularly , but in
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for 72 weeks . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 mbq given every 2 weeks . seroconversion is the method of vaccination in which hepatitis b cannot be completely eliminated by a hepatitis birus carrier . the hepatitis b antigen is prepared by recombinant dna technology . the antigen is reconstituted with a
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) undesirable effects have occurred during clinical trials with immunoglobulin ( injection into the muscle ). very common : may affect more than1 in 10 people rare : may effect up to 1 in 1
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outercarton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one ml of immunogaman contains 1 to 5 mg of human plasma protein ( equivalent to 96 mg / ml ). - the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunoglubulin .
remicade contains the active substance infliximab . infliximusab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs ' and is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older with crohn ' s
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take reminade more than once a day , contact your doctor . if any of this applies to you , tell your doctor before taking remicADE . if your child has taken rem
treatment for rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of person . the dose may be increased or decreased depending on body weight and how well the medicine works for you . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . these reactions are usually mild to minor and usually disappear within a few days . an allergic response may occur within 2 hours
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with remicade if it is not used immediately . infusion - related storage times and conditions are the responsibility of the user and would normally not be longer than 3 hours at 2 8 and 28 . however , if you are treated for an additional 24 hours at 25 , the storage times , conditions and conditions prior to
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixIMab . after dilution each ml contains 10 mg of infiximabe . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicaded is available in packs containing 1 , 2 , 3 , 4 , or 5 v
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson's disease ). with parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine that is produced in the cells and helps to control movement .
do not take rasagiline mylan - if you are allergic to rasaggiline or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a strong pain killer . it may affect the way some other medicines work . rasaga mylan treatment may be interrupted or stopped if you have treatment with mao inhibitors or pethidine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasage mylan than you should if you accidentally take too many tablets , contact your doctor immediately . take the rasaga mylan carton with you so that you can easily describe what you have taken . if possible take rrasagil
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan have been reported in patients treated with placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgiline - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid . what rasaggiline melan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , such as tuberculosis . if your children have symptoms of infections such as fever , wounds , feeling tired , dental problems . - if they have moderate or severe heart failure . - tell your doctor if your or your child ' s doctor thinks that your or their child 's heart condition is not being controlled . warnings and precautions allergic reaction allergic reactions are symptoms of chest tightness , wheezing , dizziness , swelling or a rash .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio is available as 20 mg once daily in children from 2 - 17 years old weighing 30 kg or less . hula is available in children and adolescents from 2 years of old weighing less than 30 kg . hulin is available with 40 mg once weekly in children of 6 to 17 months old weighing more than 30kg . huli
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may be serious and require urgent medical treatment . tell your doctor immediately if you notice any of the following side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash or hives swollen face , hands or feet , trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection containing 40 mg of adalimab in 0 . 8 ml of solution . it is clear and colourless to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sy
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which are used to reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed a lower dose of either : - asthma - skin allergy - intense inflammation in your nose - using other nsaids ( nsaid substances ) such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac . this medicine should not be used in combination with topical steroids ( cortisone ) as it may increase the risk of unwanted side effects . - if there have been bleeding problems ( such
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in your eye ( s ) once a day . the recommended daily dose is 2 drops in the morning and 2 drops of the same dose in the evening . the drops should be used every day until the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands thoroughly with soap and water . the eye drops should not be swallowed . remove the bottle cap from the bottle . hold the bottle , pointing down
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufantanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have ever had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is only for adults . you should swallow the tablet whole with a drink of water . do not crush or chew the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) are : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do this if you are concerned that the solution is not clear or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid and magnesium stearate . what dzuvello looks like and contents of the pack dzuveyo is a white to off - white , round edges , 3 mm in diameter , supplied in a single - dose applicator ( labelled [ sublingual tablet ]). the applicator contains
erveada is a cancer medicine containing apalutamide that is used to treat prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it is used when sensitive prostate cancer has spread beyond the original part of the original body and has not responded to surgical treatment . it works by reducing the amount of testosterone in the blood . when resistant prostate cancer is resistant to erleada , it also reduces the amount androgens produced by the cancer . by reducing levels of androgens , apalutaamide stops prostate cancer cells from growing and dividing .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . - if if you think you may ( or might become ) pregnant . ( see pregnancy and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be taken if any of these apply to you . take special care with this medicine - if any member of your family has ever had seizures . - tell your doctor if you have ever taken any medicines that can cause blood clots
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine take this tablet by mouth . do not chew , crush or split the tablet . you can take erleade with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erpleada if you miss a dose of erlea
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you have any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms ( toxic epidermal necrolysis ). serious side effects tell your doctor straight away if you notice any of these serious side side effects . fits ( seizure ) uncommon ( may affect
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erleady
this medicine is a radiopharmaceutical product that contains the active ingredient fluciclovine . axumin is used to carry out a scan ( a pet scan ) in adults who have previously had treatment for prostate cancer . it is used in combination with other tests to determine prostate specific antigen ( psa ) and the cancer . an axumin pet scan is performed to find out if the cancer has spread to other parts of the body . the scan will be recorded on the patient ' s patient alert card . the use of axumin in adults is restricted to those who are able to receive the scan . your doctor has considered that
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . axumin is given once a day for the duration of the axumin scan . this is 4 weeks . during the scan , you will be given your usual medicines to take the latest 60 minutes before the axum injection . - urination during the day after the scan . children and adolescents ax
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . axum will be given to your nuclear medicine physician by a doctor or nurse . during the procedure axumin is given into a vein
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) when using the medicine . the following other side effects have been reported when using axumin : uncommon ( affects 1 to 100 users in 1 , 000 ) pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical delivers low amounts of ionising radiation which can cause cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored under strictly controlled conditions .
what axumin contains the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 to 16000 iu ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( correspondingto 3200 to 32000 iiu ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off - white powder , with a uniform consistency . axum 1600 mg
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . when the pressure in your eye is too high , it can damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor thinks you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before taking azopt . - if the doctor thinks that you are not allergic to medicines called sulphonamides ( medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking the following : - if azopt has the same allergy as sulphonamide , but you have too much acid
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used for the eyes only . use azopt in both eyes only once a day . use in both eye and eyes only : use azop in both of your eyes once a morning , afternoon and evening , at about the same time each day . do not use azopic in both the eyes . use the same dose in both hands once a week . use both eyes once daily , at around the same times each day , at approximately the same place each day ( see section 1 ). use in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) ( effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , redening , swelling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately . do away with the bottle after first opening . do this if you notice any change in the appearance of the bottle . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzyolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called " oral medicines ". it is taken by mouth to treat diabetes by increasing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) and in children and adolescents . forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . for xiga is used for the type 1 type of diabetes in which you are overweight or obese . type 2 diabetes : where your body is not able to make enough insulin or
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor before taking this medicine : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for oral use . for type 2 diabetes : the usual dose is one tablet a day . your doctor may increase your dose to 10 mg or 5 mg once a day if you have a liver problem . your dose of forxigo is for adult patients with type 1 diabetes : your doctor will increase your dosage to 5 mg or 10 mg once daily . if you take more tablets than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , your doctor can
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema is swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) if you have type 2 diabetes , seen rarely , seen up to one in 1 , 000 patients . diabeticketoacidemia may occur with increased levels of " ketone bodies " in your urine or
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i171 ),
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged 2 and 30 years . it is used when surgery is not possible or cannot remove the tumour . it can be used alone or in combination with chemotherapy ( which destroys cancer cells ) or it can take months or years for cancer to come back .
do not take mepact : if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor . some of the effects of mepaction
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide per kilogram of body weight , given every 12 hours for 24 hours . your doctor will decide how many of your mepactor treatments you should take and will adjust your chemotherapy schedule . the maximum dose of your chemotherapy should be 36 mg per kil kilogram body weight . treatment with mepat is given by infusion into a vein ( intravenously ) over
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepACT ( transient ) and have been seen in patients receiving paracetamol . if you experience fever during treatment with mepaction , tell your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been experienced in patients who have received chemotherapy . tell your physician immediately if you have continuing fever and chills . these may be signs of a serious , possibly life - threatening , infection . rash have been observed in patients treated with mepanact . tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer carton in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection or infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer
what mepact contains the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mofamurtime . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose ') 2 - dileoylu - sn - glyco - 5 - phosphate monosodium salt ( see also section 2 " mepACT contains lactate ").
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness ( rosacea ) and redness of the face . rosica is a condition of high levels of blood flow in the facial skin that results in enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels causing the excess blood flow to reduce the redness and improve the appearance of the facial .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : if you take the medicine under the skin ( see section " warnings and symptoms "). if you have taken certain medicines for depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin or on the face . this medicine is applied on the surface of your body . it is applied in the same area as your eyes , mouth , nose or vagina . do not use mirvasoa if you notice any change in the appearance of your skin . if you use more mirvasoe mirvasos is applied only on the affected face . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your symptoms do not
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain and discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be signs of worsening of rosacea are : worsening of the treatment with symptoms ( see section 2 ' warnings and precautions '). contact allergy allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pouch tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparhydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvasop is a
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system that is needed to defend the body from infection and cancer ). bevacsizumib binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegfs protein causes blood vessels to expand , thus allowing blood vessels and oxygen to be taken out of the tumour . bevaconizumb inhibits tumour growth and allows blood
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your child is less than 6 months of age
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight depending on your condition . your dose of the mvasu will be calculated by your doctor . you will be given mvasis either every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your physician will calculate the dose you will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor straight away if you notice any of the side effects listed below . these effects may occur with mvai and chemotherapy . these side effects are usually mild to moderate . stop using mvasis and tell your healthcare professional straight away . allergic reactions if you have an allergic reaction , you may have difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions may be stored for up to 24 hours at 2 8 or refrigerated at 2 to 8 . the infusion solutions should be used immediately after dilution in a sterile environment . if not used immediately , in - use storage times and conditions prior
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevackizumabe in 1. 4 ml of water . each 16 ml vials contains 400 mg of of bevanacizumaab in 16 .5 ml of solvent . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantle cell lipoma ( mcl ). it is made from your own white blood cells called autologous anti - cd19 - transduced cd3 + cells . mantle cell cancer is a cancer that affects the immune system ( the body ' s natural defences ) that affects b - lymphocytes . mantlecell lymphoma b - cells are involved in an uncontrolled way in which they accumulate in lymph tissue ( the bone marrow ) and blood . tecartus works by attaching to the white
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ) if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if any of these apply to you . the medicine may affect the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ) if white blood cell counts are too low ( autologous use ). your doctor will do tests ( checks ) to check the lungs , heart and kidney . your doctor may also check blood pressure , which may increase the
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your cell will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will then be collected and sent back to your blood . the first dose of tecartus will be administered by a doctor or nurse . the dose of your blood will be injected into a vein over 3 to 6 hours . the number of your white white bloodcells will then slowly decrease over 2 to 3 hours . medicines given before tecartuse treatment ( lymphodep
like all medicines , this medicine can cause side effects , although not everybody gets them . if your side effects become severe , tell your doctor immediately . if you notice any of the following side effects you may need urgent medical attention : very common side effects during the tecartus infusion ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness , confusion , memory loss , disturbances of brain function including difficulty speaking , sl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 8 . do away with the vials . do throw away any medicines via wastewater or household waste
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti -cd19 car t cells equivalent to 68 x 2 cd3 cells or 106 x 106 anti - cd3 + cell . - the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag packed in a metal
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi : - if any of these apply to you ( see section 4 ) - if there is blistering of the skin ( bullous pemphigoid ). januven is not recommended if you have a disease of the pancreatreas called pancreatitis . - if the risk of gallstones is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film film - coating tablets . your doctor will tell you the dose to take . you should take this tablet once daily . if your doctor advises you to take this type of medicine , you should continue with this medicine while you are taking certain other medicines to lower blood sugar . diet and exercise can help your body use its blood sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you experience any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop taking
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack j
xultophy works by lowering blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin to control the level of sugar in your blood . the insulin that your body produces does not work as well as it should . this results in an increase in blood sugar . your doctor has prescribed insulin degludec ( a long - acting basal insulin ) to help control your blood sugar levels . it can be used alone or with liraglutide ( a type of glp - 1 ) or with insulin during meals . xultophy is also used in
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily . your doctor will monitor your blood sugar levels regularly while you are taking xultop . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ' ( a condition which occurs when your body does not produce enough sugar ), stop taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 days . you can take xupophy with or without food . xultide is supplied in a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken in steps of 1 mg of insulin degludec and 0 . 088 mg of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common ( may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur with low blood sugars . if yourblood sugar level is too low , you may have low blood glucose ( hypoglycasemia ). see section " warnings and precautions " for more information . serious allergic reaction ( anaphylactic reaction ) ( frequency not known ) if you have a serious allergic react
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at room temperature ( up to 25 ) for up to 8 weeks . after this time , use within 21 days . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg lirglutime in 3 ml solution . each vial contains 300 units of the active substance in insulin deglusudec 10 . 8 mg liraagluteide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what xultos looks like
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine works by stopping the growth and spread of cancer proteins . this helps to stop the growth or spread of these proteins . giotriv is used to treat cancer cells in adults . this type of cancer of the lung ( non - small cell lung cancer ) giotrarif is used as your first treatment after
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotralif if : you have liver problems your doctor may need to do some liver tests before you start taking this medicine . you have a severe liver disease . you suffer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate and of a short duration . during treatment , diarrhoea may occur . this is common ( may affect up to 1 in 10 people ). diarrhoehoea is usually mild and usually goes away within 2 weeks . severe diarrhoee may lead to fluid loss . this may occur up to to 1in 10 people . if you have low blood potassium and worsening kidney function , contact your doctor . if diarrhoeea occurs during treatment with giotrinif , the rash should be treated
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinb . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotreif looks like and contents of the pack giotratif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkmbi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . f508del mutation ( a type of cyst fibrosis transmembrane conductance regulator ) is a protein that is found in the lungs . the mutation causes an abnormal cftr protein . lumacafor and / or ivacafOR work together to remove the abnormal cctr protein and to increase the amount of lumacftor in your body .
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkamberi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of okambie . abnormal blood tests of the liver may be performed before orkabambi is given . tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults the recommended starting dose is 6 to 12 tablets a day . your doctor will tell you how many orkambi tablet to take . the recommended dose is : 6 to 11 tablets a morning orkababab - 100 mg tablet a day ( 2 to 12 ) for the first 12 weeks . your daily dose of orkaban is 200 mg ( 2 tablets aday ) once a day , with 2 tablets in the evening . your dose of eitherkamboni may be
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects that have been reported with orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . however , if you are given more orkamberi than you should , you may experience serious side effects . these may include : raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal )
what orkambi contains the active substances are lumacaftor and ivacaftir . orkibi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkabi 200 mg film film - coating contains 200 mg lumiacaftor or 125 mg of ivacaptor . each film - coat of orkyambi 100mg film - containing tablets each film film film coating contains 125 mg lumicaftor , 125 mg orkubi 200mg film film â coating contains cellulose , microcrystalline , cro
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors can cause death of cancer cells by interfering with an enzyme needed to repair dna . what lynparaz is used for lynparZA is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ) when the cancer has responded to
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using lynparz if any of these apply to you . if you think any of this applies to you , or if you have any further questions on the use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 6 years of age . use in children and young people do not use in this age group . other medicines and lynparaz tell your doctor if
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on your response to the doses of lynpalza capsules . tablets are not recommended . if you take more than one tablet of lynarza per day , you may experience side effects of 8 mg . you must take the tablet by mouth . in the evening , take the same dose as usual . if possible , take your tablet at bedtime . if necessary , take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store at room temperature ( up to 30 ) for a single period of up to 3 months . do this to protect from light . any capsules that are accidentally frozen should be discarded . do away with any capsules you accidentally take . the capsules should be returned to the refrigerator and discarded .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparZA is a white , opaque , hard capsule imprinted with " olaparatib 50 mg " and " astrazeneca logo " on one side . lynparanza is available in packs containing 112 hard
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and can be fatal in some cases . it is usually treated within 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an accidental overdose . if you use more nyxid than you should if you think you have used more than the recommended dose , contact your doctor or pharmacist immediately . if possible , show them this nasal spray 2 to 3 times .
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . use the spray as soon as possible . if symptoms occur , you should sit on your shoulders , ears , breastbone , sternum or inside the ear with a fingernail . 2 . clear the mouth and nose of any blockages . do not use the nasal spray in the mouth or nose . 1 ). if breathing is the chest moving , you can hear breathing sounds and breath on the cheek . overdose may occur if the response to touch or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms ( similar to those of opioid drugs ). symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxid is available in a carton containing 2
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries and in the production of sperm . it is produced when a immature egg cell is collected . ovaleaps is used in adults , adolescents and children for treatment of infertility , in combination with a medicine called " clomifene citrate " and in assisted reproductive technology procedures ( procedures to help a woman become pregnant ) in combination of
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you may have large ovaries ( sacs of fluids that carry blood from the ovaries to the womb ), ovarian cysts , unexplained vaginal bleeding . if you know you have cancer in your ovaries , womb or breasts . if any condition that makes normal pregnancy impossible ( ovarian failure , early menopause ). if any of these apply
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medicinal product is for injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you should use this medication within the first 7 days of your menstrual cycle . the medicine should be used every day . the recommended dose of this medicine is 75 mg / m2 . you should inject this medicine once every day for the first seven days of each menstrual cycle , unless your doctor tells you otherwise . the dose of the medicine is not changed . the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions ( e . g . skin rash , raised itchy areas of skin ). severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you notice this type of reaction , your ovaleape injection should be stopped immediately . serious sideeffects in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper - stimulation syndrome ( ohss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . do this medicine if it is accidentally frozen . if frozen it may be stored for a maximum of 3 days below 25 . do away with this medicine and keep it at room temperature ( not above 30 ) for no longer than 3 days . once the cartridge has
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 0 ml solution . ovaloap 450 iu in 0. 75 ml solution each cartridge produces 450 iiu 33 microgram ( 23 microgram ) folliotropin alpha in 0 .. 75 ml . ovalap 900 iu per 1 . 5ml solution for injections each cartridge releases 900 iiu of 66 microgram follitopin alga in 1 . 0
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to treat candida spots infections caused by the fungus fluconaz
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine - if allergy to astemizole - if allergic to cisapride - if stomach problems - pimozide - if mental illness is not well controlled - quinidine - if irregular heart beat - if rifampicin - if tuberculosis is not controlled - if ef
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours or 24 hours or 200 mg once every 12 hours for 24 24 hours and 200 mg twice daily for 100 hours . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly . if
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura ,
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazol ( as mesilate ) voricleazoleaccord 200 mg film film - coating : the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older : you will be given one dose of ebola vaccine ( a 2 - dose course of vaccinations ). the other ingredients are : ebola virus disease : the zaire ebolavirus and filovirus . this vaccine contains the whole ebolairus . it does not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas : vaccinations : if you are going to have a zabdeno vaccine , you should be
your child will receive the vaccination course . if your child has had a severe allergic reaction to any of the ingredients in the vaccine ( listed in section 6 ). if your baby has had such a severe allergy reaction to an antibiotic called ' gentamicin ', or any of those other ingredients of the vaccine listed in " other ingredients " below . if you have had a previous allergic reaction with any other vaccine injection . if the child fainted after the injection . warnings and precautions talk to your doctor , pharmacist or nurse before your child receives mvabea if your newborn has : a severe asthma reaction . a fever . an infection .
the recommended dose of vaccine is a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . the second vaccine will be vaccinated with mvabea yellow cap vial . the third dose of the vaccine will also be given . primary vaccination first vaccination with zabi red cap vials . second vaccination with m vabea orange cap vipline . the fourth dose of a booster vaccine will not be given until after the first vaccination . booster vaccination with either zab deno or an earlier zaben
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in 100 people ): redness and skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in 100 users ):
what mvabea contains the active substance is zaire ebolavirus 29 ( tai forest ebolovirus nucleoprotein marburg ). one dose of 0 . 7 ml contains 108 million international units ( iu ) of chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvaraa is a suspension for injection in a single - dose glass vial with a rubber sto
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it helps you to prevent other bone problems that may need surgery or radiotherapy bondronAT may also help to prevent you from having a raised calcium level in your blood due to a tumour . if calcium is lost from your bones , your bones may become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor determines that you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you have a possible side effect called osteonecrosis of the jaw ( onj ). onj can lead to bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj may also occur after stopping treatment . on j is
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests before you are given bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , your doctor may give you a lower dose of 3 mg every 3 - 4 weeks . this will be given as a single dose as an injection in your vein over a period of about 15 minutes . if there is a raised calcium level in your blood , your dose may be reduced by 1 mg every
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in up to1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems called necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2Âºc to 8Âºc unless dilution has taken place in controlled and validated aseptic conditions . do this medicine if you notice particles in the solution or if the solution is disc
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack bondronate is a clear , colourless solution for injection , supplied in a glass vial with a 1 ml or 2 ml clear glass vials closed with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsitting remitting ms is a disease that attacks on the nerve cells . the symptoms usually disappear for a few days or weeks , but some problems can be serious . how zep
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if any of these apply to you , tell your doctor . if your doctor thinks that you have irregular or abnormal heartbeats ( arrhythmia ). if your heart is not working properly after treatment . if the patient has severe infection ( such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take to control your heart rate . your doctor may prescribe you a ' treatment initiation pack ' with different doses of treatment . the recommended starting dose is 4 capsules of 0 . 23 mg ozanimod per day . this will be taken once a day for 1 week . then , 4 days of treatment will be followed by 3 capsules of 1 mg ozamanod per morning . this is followed by 4 days in a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine not use if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydrate ). ozanimode 0 . 93 mg : two capsules contain approximately 0. 92 mg ozmanimod (as hydrate ), microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03 mg : the
what temybric ellipta is temybarric elliptic contains two active substances called fluticasone furoate and umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umeleclidinnium bromeide and Vilanterrol belong to agroup of medicines known as bronchodilators . what temyborric elliptical is used for temymbric elliptaic is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temy bric elliptia - if your child has asthma . warnings and precaution talk to the doctor , nurse or pharmacist before using this medicine : - if the child has ever had asthma . temymbric elliptea should not be used in children with asthma . - if he / she has heart problems ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not take temybric ellipta more than once a week . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybubric elliptoe may include a sudden attack of breathlessness or wheezing . if
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect reported with temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat . these may be signs of a fungal
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umelidinum bromate and 55 microgram s of umclidiniaium bromeide and 22 microgramS of vilancerol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo works by killing certain bacteria that cause serious infections . zin foro is used to treat adults and children who have infections of the skin or the tissues below the skin . it is also used to prevent an infection of the lungs called ' pneumonia '. how zin Foro works zinofo works in bacteria by killingcertain bacteria that causes serious infections that may be life - threatening .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics , such as penicillin or carbapenem . warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . warnings , precautions and precautions tell your doctors before taking any of your zinofo : if you
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many doses to give you . the recommended dose is one 600 mg dose every 8 weeks . if you have some infections that you cannot tolerate for 8 weeks or more , your doctor may give you a lower dose . the dose is usually given every 8 to 12 weeks as a drip into a vein . the usual dose is 5 mg once daily . your dose may be increased to 60 mg once every 120 weeks . your physician may give an increased dose depending on how you respond to treatment . the maximum recommended dose for children and adolescents is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea or stool that contains blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may be stopped . slow bowel movement ( common , may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain pregabalinpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood
do not take pregabalin pfizer if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which could
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pfeizer once in the morning and once inthe evening . for 59 patients taking pregagalin pfingizer , take once in a morning , once in an evening
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabil . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol , potassium hydroxide ), and the 75 mg capsules contain 100 mg
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . dopamine is a chemical in the body that is important for movement . in parkinson ' s disease , the most common symptom of parkinson's disease is sudden swings in movement . people may not be able to move normally or have difficulties moving at all . xadago can be used alone or in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed any of any of these medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - if the active substance in xadagra is pethidine , a strong pain killer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you how many tablets of xADago to take . if you have moderately reduced liver function , your doctor may prescribe 50 mg twice a day ( one tablet in the morning and one tablet at the evening ). your doctor should tell you to take xadadago at least once a week . xadagon should not be taken with food . patients with
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few weeks . other medicines and
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadark looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga contains a medicine called abiraterone acetate which is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood . this helps to fight prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy or who are not taking a treatment that lowers testosterone ( androgen deprivation therapy ). it is used with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the full dose of the medicine it produces . it also
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigo - if there is severe liver damage - if this medicine has been associated with prostate cancer . if you have been taking this medicine for a long time , tell your doctor before taking this type of medicine . - if any of these apply to you , tell the doctor before you take this medicine . warnings , precautions and precautions tell your nuclear medicine doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet with food . if your child misses a dose of zytigo , take it as soon as possible and then
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . your level of potassium in your blood is low . your doctor may check your potassium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( especially in the legs ), low blood potassium ( seen in liver function test ), high blood pressure , urinary tract infection , diarrhoea common ( might affect up to 1 in every 10
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigo contains lactose "). what zytigra looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm .
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases in adults . hefiya is used for : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedial crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . adlimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfÎ± ), which is involved in the
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . if your / your child ' s doctor thinks that your or his child 's child ' re developing unusual infections , or if your own child has developed a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you / your son has moderate or severe heart failure . if he / your or her child
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe you a different dose of 20 mg or 40 mg . your child ' s doctor may decide to increase the dose to 20 mg and 40 mg depending on the child 's condition . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg once a week . children from 1 year of age weighed 10 kg or less
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - since the last hefiya injection , you may have experienced allergic reaction ( including heart failure ). - severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe must be used within 14 days or discarded
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this cell , it stops the cell from growing and dividing . how ritemva works ritemvir is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type in the body called
do not take ritemvia if you are allergic to rituximab , other proteins that are similar to ritonuximabs or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris warnings and precautions talk to your doctor before taking ritemvi if you : have ever had or might now have a hepatitis infection .
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to stop giving you this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritmvia administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , your doctor or nurse will give you
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what ritemvia contains the active substance is rituximab . each ml of solution contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contains 10 mg of the active ingredient in rituimab per ml . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemvest is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitabiline teeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitabe teva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery
do not take capecitabine teva if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . for children and adolescents ( aged 64 years and above ), the usual starting dose for children is 1 . 64 mg / kg
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhoehoea at night , vomiting , vomit , nausea and lose your appetite . stomatitis : if your doctor thinks you may have pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if pain , swelling , red or ting
what capecitabine teva contains the active substance is capecitabiline . capecitabe teva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitabee teva 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172
silodosin recordati contains silodosan recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodusin recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodnosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if eye surgery has been performed - if there is cloudiness of the lens in the eye during cataract surgery 26 - if any of these apply to you , tell your doctor before using this medicine . - if your doctor has told you that you may be at increased risk of being given medicine that causes a loss of muscle tone in the iris ( the coloured
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day , with or without food . the maximum recommended dose for adults is 8 capsules taken once daily . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodousin recordat is taken once every day , at about the same time each day . you should take the capsule at about 4 - 6 times a day . if taking silodosein record
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . if you experience any of these , tell your doctor immediately . the most common side effect of silodosin recordati is dizziness . dizziness may occur with standing up . occasionally fainting may occur . if this happens , tell the doctor as soon as possible . if your doctor feels weak or dizzy , tell him or her . the symptoms may include dizziness and faints . if any of the
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosiin recordatin 4 mg : silodosesin . what silodosisin recordi looks like and contents of the pack silodousin recordit 8 mg is supplied as white , opaque , hard gelatin capsules , imprinted with " s " on one side and " 0 " on the
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is caused by a variety of causes . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - tell the doctor if any of these apply to you . - if your doctor has prescribed diabetes or impaired kidney function and you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken with or without food . try to take your tablet at the same time each day . you can take kinzalmono with or just after food . it is important that you continue taking kinzdalmono for as long as your physician tells you to . your doctor will monitor your condition and may adjust your dose if necessary . treatment of high blood pressure the usual starting dose of kinzalano is 40 mg once a day
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events uncommon side effects : uncommon side effect ( may impact up to one
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this by gently squeezing your kinzalmono tablet out of its blister to make it easier for it to be taken home . do the same for your next dose . do away with the blister that is damaged . do throw away any medicines via wastewater or
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in the manufacturing process . the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor vii is involved in blood clotting and is necessary for blood to clot . patients with an increased tendency to bleed may also have an increased need for factor v ii . afostyla works by helping the blood to form its own clot .
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstya . the dose and the batch number are recorded in your treatment diary . do not use more afstrya than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afsttya . symptoms of allergic reactions may include allergic reactions such as hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on the severity of your disease the site and the bleeding your clinical condition will be decided by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be used immediately after reconstination . if you have aseptic conditions , you may be given afstylea
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may occur with the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding . in patients receiving factor viii medicines , inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). patients who have received previous treatment with factor v iii ( more or less than 150 days of treatment ), the risk of developing this condition is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . do away with the vial and keep it in theouter carton . do this until the reconst
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ). after reconstitution with 2 .5 mg of injections the solution contains 200 iu lonoectocog aluminium ( 12 . 0 mg ). each vials contains 1000 iu of lonoCTocog alpha . after reconitution with 1 . 5mg of injections it contains 400 iu iu / lonoclog ala ( 12 .. 0 mg ) 1500 iu . after solution for injection , 5 ml of water for injections the solutions contains 300 iu
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . how prax Bind works prax binds to pradxa and is used by doctors in emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine . serious adverse reactions have been reported with the use of prax bind in combination with this medicine with dabigatran . other medicines that may cause blood clots dabigATran is another medicine that is absorbed by the body and can cause bloodclots . medicines that can cause
the recommended dose is 5 mg / kg body weight , taken once daily . your doctor will decide the dose that is right for you . your dose will be calculated by your doctor based on your weight . the recommended dose for adults is 2 . 5 mg dabigatran per kg bodyweight , taken twice daily . this medicine will be given once daily for 5 days . this will be administered into a vein . your healthcare professional will administer this medicine to you at regular intervals . your treatment will be overseen by a doctor who is experienced in the treatment of blood clot formation . dabigATran will be stopped for 24 hours after administration
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then followed by monotherapy phase oftreatment ( phase 3 ). - in adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is given togetherwith standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness , wheezing or swelling of the face , lips , tongue or throat . if your number of blood cells is severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells are important for fighting infection and for proper blood clotting . temomed
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedic may be used alone or together with food and drink to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment together
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this may cause increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolaomide ( as mesolomides ). temomediac 20 mg :each capsule contains 20 mg tem ozolomine ( as temolomamide ). temmedac 100 mg : one capsule contains 100 mg temzolomage ( as Mesolomid ). temarthac 140 mg : the active ingredient is temolomonomide , as mesoledomide ). temarmac 180 mg : every capsule contains 180 mg temoloma ( as esolomod
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual performance . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by stopping the blood vessels in your penis from tightening . this helps your penis to work properly . erectile function is important for maintaining a healthy erection . ceralis is used to treat adult men who have erectile disease . cocal
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors such as amyl nitrite ( a group of medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you : - if : you have serious heart disease - recently
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if a child swallows some tablets , tell
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( common ) nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e132 ),
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your body or where your body does not respond normally to the insulin it produces . enyglide is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when enylid is taken in combination with metformin . if you have diabetes , eny gl
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your child has liver problems . if he / she has moderate liver 28 disease . see section 2 . warnings and precautions talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . the maximum recommended dose for adults is 30 mg once daily . the dose may be increased by 4 mg once every day . your doctor may increase your dose to 30 mg twice daily ( every 16 days ). your doctor will monitor your blood sugar regularly and may adjust your dose if necessary . if you take more enyglid than you should if you accidentally take too many enylid tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( which may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . however , hypoglycanemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include : common ( may affect more than
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains lactose "). what enyGlid looks like and contents of the pack eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myan is used for azacididine myla is used to treat adults . what it is used in adults azac citidine mylon is used : azacuitidine mygal is used after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ) and chronic myelomonocytic leukaemia ( cmml ) or acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacnitidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition ( such as heart attack ). - tell the doctor if you have lung disease
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl to give you . your dose of this medicine will depend on your height and weight . azacacitine mylan is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( such as the thigh , tummy or upper arm ). if you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . these measures will help protect the environment . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine must not be used after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the azacnitidine myla suspension must be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are
what azacitidine mylan contains - the active substance is azacitonidine . one vial of powder contains 100 mg azacituidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol . what azacididine myl looks like and contents of the pack azacnitidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacilitidine . it is supplied in packs containing 1 or 7 vials . not all pack sizes
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timolole is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye due to an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness or difficulty in breathing . - when the child is being treated for long - standing cough . - in case the child suffers from breathing problems such severe hay fever . - tell your doctor if your baby has a slow heartbeat . - have heart failure ( a disorder of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye once a day . do not use duotrav in the eyes unless your doctor tells you to . do this if you have the impression that the effect of duotra is too strong or too weak . if you use more duotrave than you should contact your doctor immediately . the number of drops you use depends on your condition and the type of eyes you are using . how to use duetrav is provided in the following pack : - eye drops :
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects on how the eye surface inflammation or surface damage can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects : ( may affects up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do away with the blister after 4 weeks to prevent infections . do this as your doctor or pharmacist has told you .
what duotrav contains the active substances are travoprost and timolol . each ml contains 40 mg travaprost and 5 mg timolole ( as timololine maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels are maintained at ph levels . what duotra looks like and contents of the pack duotrave
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts in patients with a weakened immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important in protecting the blood from blood clots . very low platelets can cause bruising and serious bleeding ( see section 1 ) in patients who have had their spleen removed . in patients suffering from chronic itp who have not previously received corticosteroids or immunoglobulins . nplate works
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been taking other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor before taking nplate : if you suffer from a low blood platelet count ( thrombocytopenia ) if you take n plate , your platelet counts may increase . if this happens , you may have blood clots . blood clogging may occur . if any of these
nplate is given to adults and adolescents ( aged 1 to 17 years ) who weigh at least 50 kg . your doctor will decide how much nplate you need and how often you need to be treated . how nplate is administered nplate will be given as an injection under the skin ( subcutaneous ) over a period of 1 hour . how often nplate should you be treated with nplate ? your doctor may check your platelet counts regularly . you will have regular blood samples taken to count your platelets . your platelelet count will be checked regularly . your blood will be taken regularly to measure your plate leaflet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ) in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indig
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the blister after 30 days . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial of 0 , 125 mg contains 250 mg romclostim ( as besilate ). each single dose vials of nplate 250 mg powderfor solution for infusion contains 375 mg romlostim , as bessilate . each dual - dosevial of n plate 500 mg powder contains 625 mg romoplostim and 500 mg
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to control breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the amount of air that gets in and around the lungs when you breathe in .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine . your doctor will decide whether treatment with tovannor breezer is appropriate for you . if you have any of these , tell your doctor immediately . - tightness of the chest , coughing , wheezing or breathlessness immediately after using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhaler twice a day . this medicine should be used within 24 hours of your last dose . the recommended starting dose is one 75 micrograms inhalation dose . you should use this product every day , at the same time each day . how to use this medicinal product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine . the medicine is inhaled using inhalation powder
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopromroniumbromide and 50 microgramS glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium per inhalation dose . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovanir breezer 44 microspheres
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious , tense . adasve can also help to reduce the effects of bipolar disorder , which can include feeling " high ",
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvey ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath 25 if you suffer from neuroleptic malignant syndrome ( nms ), which is a group of symptoms that have been reported in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( taken in 2 to 4 . 5 hours ). if your condition worsens , your doctor may prescribe a lower dose . you should take adasuve by mouth once a day , with or without food . it is important that you continue to take adasve until your doctor tells you otherwise . if you take more adasuves than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the tablet ( s
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness which may become irritating and difficult to control . these may be signs of problems with your airways ( asthma or copd ). - light - headedness or fainting . these could be signs that your blood pressure is not being controlled properly . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . adasuves delivers 4 . 5 mg / ml of lxapine in each inhaler . what adasuva looks like and contents of the pack adasuvey 4 .5 mg is a white to off - white plastic inhaler , with " loxpine " printed on the cap and " 4 . 0 " printed in black on the body . each inhalcer is packed in a sealed foil pouch . adasve is available in packs containing 4 . 4 ,
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called cytokines . what azacididine betafarm is used for azaccitidine betaparm is given to adults . azacitant betapham is used in adults who have had a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow
do not take azacitidine betapharm - if you are allergic to azac citidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azaccitidine betafarm : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack . - in patients with lung
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azaccitidine betafarm is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given on an individual skin surface ( sublimation ) or on the skin of your thigh ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . these measures will help protect the environment . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine must not be used after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . the suspension must be stored below 45 Âºc . the azacituidine betafarm suspension must not come in vials with water for injections . thesuspension must be kept in the refrigerator at
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacituidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol . what azacididine betafarm looks like and contents of the pack azacnitidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacilitidine .
celdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucosyleceramide , it can build up in your affected organs . this medicine will help you to fight this condition . your doctor will test for this medicine before you start using cerdelga . slow speed and poor metabolisers may also affect your
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 if you have moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines known to be a poor metabol
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser twice a day . the dose of metabolizer is one 84 mg tablet once a day , with or without food . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet pack with you . do not open the sleeve . you can take the tablets with or with food . you may take the dose with or just after a
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . do this medicine if you notice that the outer carton is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgi capsules are a peach
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). to reduce the amount of calcium in the blood in adult people where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the substance to which zoledicle acid belongs ), or any of the other ingredients of zoledric acid hospiral ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using zoledoral acid hospiar if you have or have ever had a kidney problem . if you experience pain , swelling or numbness
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). this is called ' iv ' administration . you must drink plenty of fluids during treatment to avoid dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on the severity of your kidney problem . how often zoledron acid hospiera is given your doctor will decide if you should be given it . if your doctor thinks that you may be at increased risk of bone complications due to
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw , or loosening of a tooth . these could be signs of bone damage in the
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this to protect from light . do away with any medicines that are damaged or shows signs of tampering . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledrine acid contains 4 mg zoledrin acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . these nerve cells are important in helping your body fight against the brain that produces its own protection ( protection ). when people are sick , they may also be sick more easily . rolapit works by stopping the production of these nerve cell cells , which help to prevent nausea and vomiting from occurring .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking varubry if you : have depression or difficulty sleeping ( see section 2 " warnings and risks "). have ever taken this medicine 27 have severe liver or kidney problems . have ever used certain medicines containing rifampicin . have had tuberculosis or other infections . have been treated
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water , with or without food , for at least 2 hours before your chemotherapy cycle . your doctor may change your dose , or stop chemotherapy completely if you experience sickness . if you have sickness after taking this medicine , your doctor will decide if you should continue chemotherapy or not . if your doctor decides to restart another chemotherapy cycle , you may be feeling sick or being sick more than before chemotherapy . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and receive appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache ; constipation ; feeling tired uncommon ( may effect up to1 in 100 people
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack var
what enerzair breezhaler is and how it works enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this makes it easier for air to get in and out of the lungs and makes it less likely that you will have to pass through them . mometsone furyate belongs to agroup of medicines known as corticosteroids
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - diabetes , high blood sugar , seizures - have severe kidney problems - suffer from severe liver problems - develop low level of potassium in your blood - have or have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day with food . use enerzair breezhaler every day , at the same time of the day . this will help you to remember to use it . if your asthma is not getting better or your symptoms get worse , you should continue to use enerzeair breezyzhalER until your doctor tells you otherwise . how to use the medicine use enertzair breezezhalzer as described
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other side side effects include the following side effects : very commonly ( may affects more than one in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do away with the capsules if you see any change to the appearance or colour of the pack . do throw away any medicines via wastewater or household waste . ask your pharm
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate and 63 microgram of glycopreyronium bromides . each delivered dose contains 50 microgram ( 3 . 5 microgram ) of glyopyrronia and 160 microgram( 3 . 4 microgram) of mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken to prevent blood cl clots ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events , which can
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopiprel or any of the other ingredients of clopidineogrel agibilise ( see section 6 ). if this applies to you , tell your doctor before taking clopidoogrelacino pharmae gmb h : if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidineogrel aclara gmbhl per day to be taken orally with or without food . you can take cloclopidoggingrel acine gmb h with or just after food . if you take more clopidoogrel agrogrogrogh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects 2 to 10 user in 10 , 000 ). not known ( frequency cannot be estimated from the available data ): very common : may affect more than 1 in 10 people . very rare : may affects lessthan 1 in10 , 000 . contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharmaceutical gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmha gmb h looks like and contents of the pack clopideogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( which is a nucleosiderase analogue reverse transcriptases inhibitor ( trti ). the other active substances in delstrigo are tenofovir disoproxil ( a nucleositide analogue reverse transcriptase inhibitor , nrti ) and tenofavir . del
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these medicines : - carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines to prevent seizure ) - rifampicin , rifapentine ( medicines used to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety .
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet once a day . your doctor will tell you how many tablets to take . the usual dose for hiv infection is 1 tablet once daily . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower your dose . taking this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if possible take the tablet with food . do this with a drink of
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do this to protect the tablets from moisture and light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material containing carnauba wax e903 , hypromeellose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171 , triacetin
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression . these include feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used in combination with another antidepressant , which is also used in children and adolescents ( aged 2 years and older ). if you have any questions about antidepressant medicines , ask your doctor or pharmacist .
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). if recently had a heart attack . within 6 weeks of starting treatment . if you notice a temporary increase in blood pressure . this can lead to serious complications in these conditions . if any of these apply to you , tell your doctor before taking spravo . warnings and precautions talk to your doctor or pharmacist before taking this medicine :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for single use only . the nasal spray device is for use in children and adolescents ( aged 1 year and above ). the recommended dose is 2 sprays . 3 nasal spray devices are for use together with one nasal spraydevice . if you use more spravata than you should if you have used more spradato than you have been told to use , contact your doctor immediately . if possible , use the nasal spray device at least
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from others , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria , feeling agitated , feeling anxious , eyes , ears , sense of touch are altered or mimicked irritable panic attacks change in perception 37 feeling ,
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketine . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spray unit . spravata is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . each spray device is sealed in a sealed
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body , or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene called ' melanoma ' that makes it harder for cells to grow . zelboraf targets proteins that are involved in the growth of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if allergic reactions occur during treatment with zelbaraf , tell the doctor or nurse immediately if you have any symptoms of an allergic reaction , such as swelling ofthe face , lip or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment may be stopped if you take more zelboraf than you should if you have taken too many tablets . if you accidentally take too many capsules , contact your doctor immediately . vomiting has been reported in patients taking zelbaf . take zelberaf on an empty stomach . swallow the capsules whole with a glass of water
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment tell your nuclear medicine doctor immediately : if you get any of these symptoms , including skin rash , blistering , peeling or discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophag
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating containing iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbaf
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavan is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asca ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( such as asthma , nasal discharge , runny nose , polyps or any other type of growth in the nose ) if any of these apply to you , tell your doctor before taking duoplin . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , contact your doctor immediately . if a heart attack occurs , take duaplavin immediately and contact your nearest emergency department because of the increased risk of bleeding . if possible take duplavin with food . if more than
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine not use if you notice any visible sign of deterioration . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances , clopidogrel , acetylsalicylic acid (asa ), and acetylsuicylic acids ( as acetylnitol ). each 75 mg tablet contains acetylsynicylicacid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal an
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonidrate belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure on the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have been taking medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you feel that the effect of simbratinza is too strong or too weak , talk to your doctor or pharmacist
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza is for use in both eyes . use in the eyes only . avoid contact with the drops in both of your eyes . wash your hands thoroughly with soap and water ( see section 2 ' how to use simbrinusza '). remove the cap and snap collar . before using the medicine , twist off the cap . fingers are not allowed to touch the inside of the bottle . before opening the bottle , pull down the lower part of your thumb ( between your fingers ) and tilt your head
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : other medicines containing brinzolamide or brimonidine . common side effects ( may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 weeks to prevent infections . do away with the bottle once you have opened it and put a new bottle on it . do this once a month . do no more than once a year . do throw away any medicines via wastewater or household waste .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of of brimonate tartrate equivalent to 1 . 3 mg of Brimonidine ). the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonic chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water , hydro chloride
what filgrastim ratiopharm is filgrastaim ratisopharm contains the active substance filgrasteim . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein ( granulocyte - colony stimulating factor ) produced by your own body . filfilgrastam stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim helps to increase the number of white blood cells in your body . what filgrat
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm : - if a cough , fever or difficulty breathing has been reported . - if your doctor has told you that you have a pulmonary disorder . tell your doctor if you have any of these conditions . side effects if you get sickle cell disease 57 if you feel left upper abdominal pain or pain at the tip of your shoulder .
how much filgrastim ratiopharm is given the amount of filgrasteim ratisopharm you will receive will depend on your condition and on how well you respond to filgrastaim ratitopharm . filgrateim ratiotopharm treatment will be started by a doctor who is experienced in the use of chemotherapy . the usual dose is 0 . 5 mg per kilogram bodyweight . your doctor will decide how many treatments you need and how long you will need . the dose may be increased or decreased depending on your disease types . the maximum recommended dose of fil grastim ratioph
you should not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not have left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder , see section 4 . if any of the above apply to you , tell your doctor before you are given filgrimastim ratiopharm . your doctor will decide if you should be given this medicine . your dose of filgrasteim ratisopharm will depend on the number of neutrophils ( a type of white blood cells ) in your blood and on the results of treatment .
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrateim . filgraspim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastrim in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre - drawn syringe containing 48 mg of the active ingredient filgrasterim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to the nervous system . what rilzole zintiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) - motor neurone disease ( ms ) in which the nerve cells that carry nerve cells out of the muscles suffer from weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . r
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been associated with increased blood levels of some enzymes of the liver called transaminases . - if your doctor thinks that you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta - if : you have any liver problems - yellowing of your skin or the whites of your eyes ( jaundice ) - itching , feeling sick or being sick ( which may be due to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . your doctor may prescribe a lower dose for up to 12 weeks . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your child ' s doctor , hospital pharmacist , or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . a blood sample will be taken to check white blood cell counts and may help you to fight infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests before and
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with ' 50 ' on one side . riluxole zartiva is available in packs containing 202 tablets . rilan
the active ingredient in emgality is galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which patients have increased levels of cgrm in their blood . emgalis is used to treat migraine in adults , adolescents and children aged 4 years and older who have migraines . emigality is used in adults to reduce the frequency and severity of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can cause allergic reactions emgally can cause serious allergic reactions . these reactions may be life - threatening . you should see your doctor immediately if you experience 40 signs of a serious allergic reaction . such signs may be serious and cause side effects listed in appendix 4 . children and adolescents emgali is not recommended for children and teenagers under the age of 18 years . other medicines and emgalis tell your doctor or pharm
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or at the same time each day . after proper training , you should receive emgals 240 mg twice daily . do not inject a double dose to make up for a forgotten dose . if you have any further questions on the use of emgaly , ask your doctor , pharmacist or nurse . if your doctor thinks
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product may be stored for up to 7 days at room temperature ( up to 30 ) before being used . do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumb in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is supplied as single - dose pen in packs of 1 , 2 , 3 or four pre - fill pens
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occclusive disease ( when the blood vessels in the liver become damaged ) in adults , when blood clots are too high to be treated with medicines obtained prior to a stem cell transplantation . defibrorotide works by helping the blood vessel to open and close , so that the blood clasts can be removed . your doctor has prescribed this medicine for you because you have not been trained .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures if you : have bleeding , especially if you get heavy bleeding ( if you need a blood transfusion or surgery ) have problems with blood circulation ( if there is a constant blood pressure ) have a history of blood clotting ( see section 1 ) have taken
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given to you directly into one of your veins ( known as an ' intravenous infusion ') or drip . you will receive this treatment for 21 days after your symptoms are stabilised . if you have any further questions on the use of this medicine , ask your doctor or nurse . if more than 18 weeks have passed since you received your first dose of defitELio , tell your doctor , nurse or pharmacist . if possible , take the next dose at the usual time . do not
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ): bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use defnitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active ingredient in defibritide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . see section 2 " defitelsio contains sodium ". what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it is supplied
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat the hepatitis C infection . your doctor will discuss with you which combination of the other medicines is best for you . if you have any questions about how daklanza works or why this medicine has been prescribed for you , ask your doctor .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with any of your following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital used to treat epileptic seizures rifampicin , rifabutin and rifapentine antibiotics used to prevent tuberculosis dexamethasone , a steroid used to correct allergic and inflammatory diseases , medicines containing st . john ' s wort ( hypericum perfor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this to avoid unpleasant taste . your doctor may tell you to take daklanza with some other medicines . if you have any further questions on the use of dailinza , ask your doctor , pharmacist or nurse . if your doctor thinks that daklonza is inappropriate for you , ask the doctor , nurse or pharmaceutist . if it is
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daklineza in tandem with sofiosbuv and ribvirin has also been associated . very common : side effects ( may affects more than1 in 10 users
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30 mg film
proquad is a vaccine that protects against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is intended for use in adults and adolescents aged 9 years and older . it is used in combination with national vaccination schedules . measles is caused by live viruses that cause measles , like mumps and rubella . rubella is caused in chickenpox
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin if you have a blood disorder or type of cancer that affects the immune system , or if treatment with medications that weaken the immunesystem is contraindicated ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). if you suffer from a weakened immune system or a disease ( including aids ) with congenital or hereditary immunodeficiency ( immune competence ) or active
proquad is given by injection into a muscle ( subcutaneous ) or under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle ( usually the thigh area ) or into the upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the same skin may increase the risk of bleeding . if this happens , proquad will be injected into a blood vessel . proquad is recommended for injection in children and adolescents from 9 to 12 years of age . children from 9 years of old who have chickenpox or
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side effect that have occurred with pro quad include : very common ( may affects more than 1 in
what proquad contains the active substances are : measles virus1 , edmonston strain , equivalent to 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , corresponding to 4 . 30 mg rubella virus2 , strain , approximate 3 .00 mg varicella virus3 , merck strain , approximately 3 . 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like
jylamvo is an anticancer medicine which reduces unwanted reactions and is an immunosuppressive agent . jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( where the patients have polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older . it is used in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe or disabling psoriasis in adults who have not responded to treatment with phototherapy , psoralen , ultraviolet a radiation (
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if any of these apply to you , tell your doctor before using jylimvo . if you develop blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you have been told by your doctor that you suffer or have a weakened immune system if you think you have ever had a serious infection such as tuberculosis
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will recommend the treatment that is right for you . for rheumatoid arthritis , severe juvenile idiopathic arthritis , and severe psoriasis , for severe psoriatic arthritis , jylimvo is used as a long - term treatment . jyslamvo is also used for rumatic and skin diseases , such as jia , psorism and psoriatics . your physician will prescribe j
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be administered immediately after preparation in order for accidental spillage to be avoided . after preparation , the product should be used within 3 hours . do away with any unused medicine or waste material . this includes any unused product or waste materials . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotreate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydhydroxy benzoate and sodium methyl paraahhydrobenzoat "). what jyamvo looks like and
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help to lower breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd on your
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if this applies to you , tell your doctor before treatment with enurevi breez inhaler . if you have any of these conditions , tell the doctor immediately : - tightness of the chest , coughing , wheezing or breathlessness immediately after using
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhaler once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75 Âºc . you can use this medicinal for as long as your prescribed dose . do not use this product if you have not used it before . how to use this leaflet for instructions on how to prepare and use this type of medicine , please see the box at the end of this leafle . how much to use the instructions for use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious : very common ( may affect more than 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger , frequent urination , rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). other side effects include some sideeffects not known ( frequency cannot be estimated from the available data ) other sideeffects include : frequency
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycopreyroniumbromide ( equivalent to 50 microgram of glyopyrronia ). - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium . - the other ingredients of the inhaled powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezer 44 microsp
what riximyo is riximusyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , it stops the cell from growing and dividing . how rixima works riximalyo is used for the treatment of several different conditions . rixibyo is given to adults with a ) non - hodgkin ' s lymphoma . this is an disease of the
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixamyo . if any
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you experience any side effects , your doctor may decide to change your dose . rixima is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also monitor you during your treatment . for non - hodgkin
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab 10 mg . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied in
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has not responded to chemotherapy or is advanced cervical cancer that cannot be controlled by surgery or radiotherapy . in this case topotican actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ if your blood cell counts are too low . your doctor may decide to reduce your dose of topotican actis . - if any kidney problems . your dose should be adjusted before using this medicine . warnings and precaution talk to the doctor or nurse before using the combination of toprotecanactavis and if you have severe kidney impairment . - liver problems . top
your doctor will determine the dose of topotecan actavis you will receive based on the disease and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer , the usual starting dose is 0 . 75 mg per sq metre of surface areafor 3 days . after this treatmentcycle , your doctor will decide whether you should be given cervical cancer alone or with another anticancer medicines containing cisplatin . cisplin is used if you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . your doctor may need to adjust your dose . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections and lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 hours at 2 and 8 , respectively . from a microbiological point of view , the drug product solution should be used immediately . dilution in solutions for infusion ( nacl 0 . 9 %)
what topotecan actavis contains the active substance is topotan . 1 ml contains 4 mg topotecaan ( as hydrochloride ). after reconstitution 1 ml of solution contains 1 mg topetecan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan activ is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve . pack sizes : 1
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetyl acetylCHoline : acetylchlorolinescerase and butyrylcholinesterster
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been severe . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . if you have : - irregular or slow heartbeat - an active stomach ulcer - difficulties in passing urine - seizures - asthma - severe respiratory
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may increase your dose depending on your weight . your dose will depend on how well you respond and how well your medicine is working for you . if you take more rivasta hexal than you should if you have taken more rvast
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riastig
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be used alone or with a specific anticancer medicine containing sorafenib . what cabometyx does cabomety works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the formation of new blood vessels . by blocking these proteins , cabometometyx can kill high amounts in cancer cells . if you have any questions about how cabometx works
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : - if your doctor has told you that you have high blood pressure - if the patient has an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if patients have diarrhoea - if they have had recent or significant bleeding - if surgery has taken place within the last month - if a patient is having surgical procedures (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your treatment if necessary if you experience serious side effects . your treatment with cabometyx will usually be started over 60 minutes . you should take cabometometyx for 2 hours before or 2 hours after food . you can take cabometricyx with or without water . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more cabomety than you should if you accidentally take too many tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor or nurse straight away if your side effects become severe or uncontrollable . these side effects can be serious and require urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or unpredictable bleeding , with symptoms such as vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains cabackantinab . cabobometyx 40 mg : one tablet contains Cabozanthinib (s ) and Malate . each adult film - coated tablet of 40 mg contains Cabackantrinib . cabibometyx 60 mg : the active substance is cabozutinib . each film - coating of 60 mg contains hydroxypropyl cellulose , croscarmellose
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemphrexedospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine if pemetrixed hospir is suitable for you if you have lung cancer at an
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetretted hospir . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetxed hospiar if you have or have had problems with your kidneys . before you receive pemeted hospiera , your doctor will check the amount of fluid in your blood ( kidney and
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will work out this body surface area based on your weight and your response to treatment , and will adjust the dose based on the results of your blood cell counts . when mixed with the pemetreed hospir powder 9 mg / ml ( 0 . 9 %) solution for injection , or sodium chloride solution for infusion , you will receive pemetretted hospire in one of your veins . the infusion will last
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( common ). if you develop pain , redness , swelling or sores in your mouth ( common ), allergic reaction ( uncommon ). if any of the following causes skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2Âºc to 8Âºc . the reconstuted solution should be used immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be disposed of . any unused
what pemetrexed hospira contains the active substance is pemetre . pemetrionospira 100 mg : each vial contains 100 milligrams of pemetereed ( as pemetreted disodium hemipentahydrate ). pemetirionospirion 500 mg : one vial of 500 milligram of pememetrexED ( as peemetrexede disodium emipenthydrate ) contains 1 , 000 milliggrams of pererexed . after reconstitution , the solution contains 25 mg / ml of petrexed ( without further
ganfort contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work together by blocking a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort looks like and contents of the pack ganint is a clear , watery liquid that is injected into the eye by your eye . it is used in adults , adolescents and children aged one year and above . the eye is the clear , moisture liquid that comes into contact with the
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness and difficulty in breathing ) if your child has long - standing cough if you suffer from heart problems ( signs may include low heart rate or heart block ) if any of these apply to your child , tell your doctor . warnings and precautions talk to your doctor before using this medicine : if your baby
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use glanfort your eye will be checked before treatment starts . the bottle is for single use only . do not put the bottle in your neck . 5 . gently squeeze the bottle . 1 . wash your hands . do this with your hands or on your head . 2 . pull down your eyelid , which is closed by a small pocket . 3 . gently press down on your eye during treatment . 4 . gently pull down the lid of your eye . 5. gently squeeze your eye with
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects . ganart ( multi - dose or single - dose ) can cause very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) are : sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , redness and itching of the eyelids , hair growing around the eye . dark
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if you notice that the solution is not clear or contains particles , you should throw away the solution 4 weeks after you first opened it . do this and return the container to the refrigerator . do away with any unused solution after this time period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each bottle contains 5 mg of timolole maleate in 6 . 8 ml of solution . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganart is a clear to slightly yellow , clear , colourless to slightly brown solution for injection
gefitinib mylan contains the active substance gefitinib . this protein is designed to kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinibmylan if : you have any other lung problems . some lung problems may be serious . gefinib melan should not be used if you have problems with your liver . gifitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach for 2 to 3 days . the total recommended dose for adults is 1 tablet once daily . you should take gefitinib mylan at the same time each day . if you have trouble swallowing the tablet , you can use any other liquids . the tablet can be taken with or just after food . the maximum recommended dose should not exceed 20
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever ). these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body . the
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what gefitoninib melan looks like and contents of the
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can include a low red blood cell count ( anaemia ) and cannot be treated with red blood infusion . reblozey is used : to treat anaemia in patients with mds who cannot be cured with red cell transfusions , in combination with erythropoietin therapies ( erythrolysis ) or beta - thalassaemia
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . your doctor may decide to restart hormone replacement therapy if you had a previous blood clot or if preventive measures ( including medicines ) are not sufficient to prevent a blood clot . if you suffer from high blood pressure , your doctor will decide whether re
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you use reblozyl . reblzyl is given as an injection under the skin . the injections should be given every three weeks . the recommended dose is 1 . 0 mg for every kg of body weight . your dose may be adjusted by your doctor depending on your blood pressure . use in children and adolescents rebl ozyl is used to treat myelodysplastic syndromes . the maximum single dose is given to children of 1 . 75
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision , which could be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours or at room temperatures up to 24 hours ( below 2 ) for no longer than 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg luspaterscept . after reconstitution , each mlof solution contains 50 mg of luspormcept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . rebloyyl 25 mg / 75 mg solution for injection
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking the growth or spread of new blood vessels . fotivada is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a low level of st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda if any of these apply to you . high blood pressure tell your doctor if you think any of this applies to you , or if you feel any of your blood pressure is not being controlled with a medicine . fotivada will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day ( 21 capsules ) for 7 days . this means that you take 1 capsule of capsules once a morning ( breakfast ) and 4 capsules once daily ( evening ). your doctor will decide how many capsules to take . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotrevda therapy . the usual dose of the fot
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you have high bloodpressure . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may need to adjust your dose of fotivda . high blood hypertension can also be treated with a medicine to treat your high blood blood pressure . if you take more fotvda than you should if you
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tiv ozanib ( as tivuzanib hydrochloride monohydrate ). the other ingredients are : capsule content : 890mg tivzanib , mannitol , magnesium stearate capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide , e171 ) tartrazine aluminium lake ( e133 ) printing
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of elvitagravir emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called a truncotide reverse transcriptases inhibitor ( rtrti ). stribild is used for the treatment of human immunodeficiency virus ( hiv ) infection in adults . st
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disopicroxil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( an enlarged prostate gland ), amiodarone , quinidine ( used to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablets 35 once daily by mouth . you should continue to take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you have been taking medicines called oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for more than 4 weeks . take the tablet at least 4 hours before or at least one hour after taking stribild
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects are caused by stribild or by the hiva disease itself . serious side effects can occur . tell your doctor immediately if you experience any of the following : lactic acidosis
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtritabine , 245 mg tenofavir disopicroxil and 300 mg ten ofovir desoproxel fumarate , each containing 136 mg tenorovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose , lactose monohydrate ,
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypoxa . zypitxa is not recommended for elderly patients with dementia because it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . your doctor may increase your dose to one 5 mg tablet once a week or to one 20 mg tablet twice a day depending on your symptoms . swallow the tablet whole with a glass of water . do not chew or crush the tablet . zzyprexa can be taken with or without food . take your zypxa tablets at the same time each day . it is important that you take your tablets at least one hour before or one hour after
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . - the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypoxa 2 . 4 mg , 10mg
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that your body makes . this helps to keep bones healthy after the menopause . when oestrogens level drops too much , bones become thin and fragile . osteopORosis is a condition in which osteoporsosis is not
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think you may have a skin infection , please tell your doctor . symptoms include a swollen , red area of skin , usually in the leg , which feels hot and tender . if this happens , tell your physician . if your doctor thinks you may be suffering from cellulitis , symptoms include fever . these symptoms may be due to an
what prolia is prolia contains one pre - filled syringe ( 60 ml ) that should be injected every 6 weeks . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia yourself or with a caregiver . you should wear stickers to help you remember to use it . you may also be given calcium and vitamin d supplements while you are taking prolia . how prolia works prolia comes as a pre - mixed syringe . it should be used immediately after the injection . you will be given injections every 6 months until
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor immediately if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , the dose should not exceed 25 ml . the injection may be stored at room temperature ( up to 25 ) for a single period of maximum 30 days . do away with the vials and keep the syringe in the carton . do this as long as it is of
what prolia contains - the active substance is denosumab . 1 ml solution contains 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection : the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick ( have a fever ), aches , pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person .
you must not be given ambirix if you are allergic to ambirux or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have had an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given ambira if you : have ever had hepatitis a or hepatitis b diseases . have a severe infection with a high temperature . the vaccine should be given at the same time every year
your doctor or nurse will give you ambirix as an injection into the muscle of your upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , make another one as soon as possible . if it is within 12 weeks after the missed one , make a new one as early as possible and then make another . if the missed two doses are not enough , make your next scheduled injection as soon after the second injection . if your doctor thinks that the missed dose
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to hepatitis b surface antigen ). the other ingredients are 20 microgram ( 0 . 5 ml ) of human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky
what bexsero is bex serumo is a meningococcal group b vaccine . what bex sero is used for bexestero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for many types of infections , including meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). how bexvero works the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bexero if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination of patients with haemophilia a if you have any other problem that may prevent your blood from clotting properly . you are treated with blood thinners ( anticoagulants ) or treatment that strengthens your immune system ( eculizumab ). if you think you
your doctor or nurse will give you bexsero at the recommended dose ( dose ) of 5 micrograms injected into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . the first dose will be administered at least 5 days apart . after three injections , the vaccine may be administered as an additional injection ( booster ). the first injection will be postponed until 2 weeks after the interval between injections . this will take 1 month . the intervalbetween injections will usually be 2 months . your doctor will give a booster to you at least 15 days apart , and at least 6 weeks after your
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of injection at the time of injection if any of these side effects occur , stop using this vaccine and tell a doctor straight away . common ( might affect up to 1 in every 10 people ) fever , loss of
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidas group b noada protein 1 and 2 , 2 and 3 50 microgreens recombinant neoisseria meingitis group b fhbp fusion protein 3 and 4 , 1 , 3 , and 50microgreens ( recombinant noisseria meningitidis type b f hbp fusionprotein 3 and 3 ) produced by recombinant dna technology . the other ingredients are : o o
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children aged 1 year and above . due to this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisine stops tyrosinone from working properly and helps to remove the harmful substances from your body . this means that tyrosaline is eliminated from your system by low tyrosines and phenylalanine ( another amino acid ).
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k may affect the eyes . during nitisinfone treatment , red eyes may occur . tell your doctor immediately if you have an eye examination . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor may decide to stop the treatment . your doctor will take blood samples during the treatment to monitor for side effects . blood disorders
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister if you notice it is not clear . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisinnone mdky 2 mg : each capsule contains 2 mg nitisine . nisinone dk 5 mg : one capsule contains 5 mg nisine . each capsule of nitisrinone mdks 10 mg : two capsules contain 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitishinone mdka looks like and contents of the pack nitisinfone mdyk capsules are 15 . 7 mm long , hard
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docenaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer either docetacin or doxorubicin , or trastuzumab , or capecitabine : - if you have early breast cancer with or without lymph node involvement , docetap
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if there is a severe liver disease warnings and precautions before you are given docetayel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may occur . tell your doctor immediately if you experience : - fever or infections . tell the doctor immediately of abdominal pain , tenderness
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken regularly to check your generalcondition . docetAXel accord should be administered once a week in the presence of diarrhoea , sores in the mouth
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel accord may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( very common ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . do away with the vial once it has been opened . after dilution , the medicine should be transferred from the infusion bag to the infusion vial immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg doceta . each 1 ml of the concentrate contains 20mg docetayel . one 4 ml of each concentrate contains 80 mg docelaxel . the 8 ml vial contains 160 mg doceteaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docet acid anhydrated "), citric acid an hydrous ( e172 ). what docetAXel accord looks like and contents of the pack docetx
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product works by reducing the activity of the brain , allowing the brain to produce more information that is useful in learning and reacting normally . this means that the brain can produce more of the information it needs to react normally and to react more effectively to situations that are unusual for you . this is called impulsive or hyperactive . this type of this medicine is called ' attention deficit hyperactivity disorder ' and is used in adults with adhd who are not adequately controlled with currentstimulant medication . it
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . you are at risk of any other psychiatric conditions ( withdrawal symptoms ). increased heart rate . high bloodpressure . do not take this medicine if any of these apply to you . if you think any of this applies to you , tell
your treatment will be overseen by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . the dose will depend on your condition and your response to your treatment . the starting dose is 1 tablet once daily . your treatment will gradually increase to a total of 0 . 05 mg / kg of bodyweight once daily during the first 7 days of treatment . your dose may be adjusted to be adjusted by your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should talk to your doctor straight away . your doctor may need to adjust your dose of your medicine . serious side effects tell your doctor immediately if you notice any of the following serious side effect : feeling drowsy ( feeling dizzy ), hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one week after first opening of blister pack . do this to protect from moisture . do away with the tablets if you notice any particles in the tablet or the tablets are damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each extended - release dose contains 2 mg guinfacine ( see section 2 ). each prolonged prolonged -release tablet contains 3 mg guenfacine [ see section 3 ' intuniver contains more guanfu '). each prolonged release dose provides 4 mg guamanfacine . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a , crosp
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection affecting the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections caused by the lack of fungillus - like fungal cell walls . ecalda is indicated in adults because it is thought that fungalcells have incomplete or defective cell walls , which may make them fragile and unable to
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . if you develop liver problems during or after your treatment with anaesthetics , your doctor may decide to temporarily stop your treatment . if any of these apply to you , tell your doctor . warnings and symptoms talk to the doctor or hospital pharmacist before using this medicine . if ecaltfa is
the treatment will be started by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 mg / kg ( 18 mg / mÂ² ) given once every three weeks . the doctor will decide how many treatments you need . the starting dose is 3 . 0 mg / 200 mg given twice a week ( 1 . 5 mg / ml ) given every three week . your doctor will determine the dose that is right for you . the patient ' s weight will be calculated by your doctor . ecalta is given as slow infusion ( a drip into a vein ) over a period of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . if the infusion solution is not used within 25 hours it should be stored in a refrigerated unit
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltva is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v ii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v viii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia a . your doctor will decide how much adynov you need and how often you need to take it . treatment of bleeding your doctor may decide to stop treatment with adnovi or to start the replacement therapy . adynova is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adynoc is 40 mg once a day . your dose may be increased to 50 mg once daily for 2 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see section
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening of the powder vial , use within 30 days or 3 days . do away with the vials . this medicine may be stored for a maximum of 3 days in a freezer ( 2 - 8 ) or for a single period of up to 3
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial is supplied with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane
rekovelle contains follitropin delta , a follicle stimulating hormone . it belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they work by helping the ovaries produce many egg sacs .
do not use this medicine if any of your fertility problems are serious , if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus if you develop enlarged ovaries or cysts on your ovaries if you suffer from polycystic ovarian disease if you experience bleeding from the vagina at an early menopause if you know that you have malformations of the sexual organs that could prevent pregnancy , or if you had fibroids of the uterus that could delay
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will tell you how much anti - mÃ¼llerian hormone to take . your ovaries will be stimulated with gonadotropins in your blood . your body weight will be checked by your doctor . your dose will depend on a blood sample taken every 12 months for the first course of treatment . your physician will then adjust your dose based on your bodyweight . treatment will be started as a single injection . the dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tiredness and fatigue
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , the solution may be stored at room temperature ( up to 25 ) for up to 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days at 28 to 25 . during the treatment any unused
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient of folliotropin delta in each millilitere of solution ( corresponding to 12 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptoe contains flutic asone furaate and 92 mg vilancerol . the 22 mg / 22 mg inhalation dose of fluticasaone fureate and 184 mg vilterol is equivalent to 92 / 22 . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . asthma in adults the 184 mg / 23 mg inhalations are used to treat asthma in adult patients (
do not take ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ellipta . ellipta should not be used if you have liver disease . tell your doctor if you experience any of these side effects . if you suffer from moderate or severe liver disease , the lower strength of revinty ellipta 92 / 22 mg may be more appropriate for you . tell the doctor if : you have heart problems , high blood pressure , tuberculosis ( tb )
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose for asthma is two inhalations ( fluticasone furoate 22 mg and vilanterol ) once a day . for severe asthma , the higher strength inhaler ( flocasonefuroate 21 mg and 22 mg vilancerol ) is used . copd the recommended starting dose for copd is two capsules ( flucasone fentanyl 22 mg or 22 mg of vilansterol ) twice a day
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , usually of the face or mouth ( angioedema ), feeling very wheezy or coughing , difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ), immediate breathing difficulties . immediate breathing problems stop taking revinty ellipta and
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgramS inhalation provides 184 microliters of flilitasonefuroate , 22 microgram of vilterol and 3 microlitr trifnatate respectively . the other ingredients are lactose monohydrate ( see section 2 under ' revintchy ellipta contents '), magnesium st
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme inhibitor ( netrti ). these active substances are used in combination with antiretroviral medicines to reduce the amount of an enzyme ( reverse transcriptasing ) produced by the virus . atripla is a treatment for human immunob
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach ( 1 to 2 hours apart ). some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you have taken more atrippla than your doctor tells you to , contact your doctor immediately . if possible , take your tablets with you . atripla can be taken with or without food .
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) rare ( may affect up to 1 in 1 , 000 people ) serious side effect tell your doctor immediately if you notice any of the following serious side side effects : lactic ache (
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg eflavirenz and 200 mg emtritabine , 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating contains
orgalutran contains ganirelix which belongs to a class of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophins releasing hormone ( gnrh ). gnrh regulates the release of gonadotropins and follicle stimulating hormone ( fsh ). gonadrophins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells that are then collected and given to you as follicles . they are then grown in the laboratory and
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . these may be signs of an active allergic condition . your doctor will do additional monitoring during treatment . allergic reactions if you have allergic reactions ( generalised , e . g . h
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is given to you by a doctor who is experienced in the treatment of assisted reproduction techniques , including in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will decide how many cycles you should receive orgaluitran . the preparation is for injection under the same skin
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a side effect , tell your doctor immediately . very common ( may affect more than 1 in 10 people ) local skin reactions ( including redness and swelling ). the local reaction usually disappears in about 4 to 1 in 100 people . uncommon ( may affects up to 1in 100 people ) headache nausea ( malaise ) rare ( may affecting up to1 in 10 , 000 people ) allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . syringes should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do away with syringers that contain clear , liquid - free solutions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( see section 2 ). - the ph is sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not all pack sizes may be marketed
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". this is a type of white blood cell that attaches to a specific target in the body . when ritukimab sticks to this target , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue that affects the immune system . it affects a type ( white blood type ) called b - lymphocytes . blitzima may be used alone or in combination with other medicines called "
do not use blitzima - if you are allergic to rituximab , other proteins that are similar to ritonuximib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has a severe active infection - if he / she has a weak immune system - if the child has severe heart failure or severe uncontrolled heart disease - if any of these apply to your child ( see section " warnings and precautions ") warnings and risks talk to your doctor or pharmacist before using blitzima if your baby has granulomatosis , polyangiitis , microscopic polyangia
how much blitzima is given your doctor will decide how much blitzimima you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you experience any side effects , your doctor may reduce your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). it is given to you by a doctor or nurse who is experienced in the use of medicines similar to that given by your doctor . with each blitzima administration , you will be treated with blitzima together with other medicines ( pre -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do away with the viodas . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritudimab 10 ml solution . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain called interleukin - 6 ( interlek - 6 ). interleukoencel is a protein that is involved in causing the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in the joints caused by the disease . roACTemra is used to treat moderate to severe active rheumatoid arthritis (
do not use roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you have an active , severe infection . warnings and precautions talk to your doctor or nurse before the infusion with roactemnra if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash during or after the infusion . infection tell your doctor immediately if you feel unwell after using roactema . this may increase your body ' s ability to fight
the doctor or nurse will give you roactemra by a drip into a vein . a doctor or a nurse will supervise the intravenous infusion and will decide on the treatment . the recommended dose of roacterera is 8 mg / kg body weight . the usual dose is 4 mg /kg body weight once a day . the dose of rifampicin is 4mg / kg ( body weight ) once a morning . the treatment will be given to you by a doctor , nurse or pharmacist . the maximum dose of the roactemera is 30 mg / kilograms body weight twice a day for 12 weeks
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in patients taking roactremra : serious side effects ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and cause skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur in up to1 in 1000 people )
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this medicine if you notice any particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg ( 20mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack ro
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbreza breezcheler is prescribed to help adults with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs , making it easier for air to get in and out of the lungs
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if there are any signs of heart problems such as epilepsy , thyroid gland problems ( thyrotoxicosis ), or diabetes . treatment with on brez breezerhaler should be stopped immediately if you get tightness of the chest
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) twice a week . your doctor will decide how long you need to continue the treatment and will tell you how long your inhaler needs to be used . the recommended dose is 24 capsules twice a night ( one 150 micgram capsule and one 300 micgram ) once a day . your dose may be increased or decreased depending on how you respond to the treatment . you should use your inhalER at least 24 hours after you
what onbrez breezhaler contains - each onbreez breez inhaler 150 micrograms inhaler contains 150 microliters of indacaterol ( as indacareol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez brez breexhaler 300 microgramS inhaler 300 micrometre inhaler containing 300 microlitres of indiacaterol , as indaconaterol maleine . - the ingredients are made of lactose or the capsule contains gelatin . what onbrex breezer looks like and contents
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs : if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions the following apply to all people taking clapidogl hcs . if : you have an increased risk of bleeding such a medicalcondition that puts you at risk of internal bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that have not responded to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj : if you have ever had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . if this happens , stop using fetroja and tell
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your first dose will usually be given by a nurse or doctor . if you are given more fetcrojas than you should if you have been given too much fetcroje , your doctor may decide to reduce your dose of fetcroJA . your next dose will also be given through a vein ( intravenously ). if you suffer from kidney problems if you receive more
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction ( sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions with difficulty swallowing or breathing ). if you have this reaction , you may have diarrhoea , stools , blood or mucus , which may be more common at the start of treatment or if you are taking medicines to slow bowel movement . other side effects include : very common side effects ( may
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system include convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop taking depocyte and tell your doctor immediately . taking any dexamethasone tablets at the same time may increase the risk of unwanted effects . if your side effects are not well controlled ,
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the care of patients . depocyte will be given to you by a qualified healthcare professional . depocytes will be prepared and given to your child by a healthcare professional in a hospital or clinic . the recommended dose is one vial of depocyte per day . the amount of injections given will be calculated by your child ' s doctor . the dose will be adjusted by your doctor based on your child '. the recommended daily dose is 1 vial ( 5 mg ) of dexamethasone 5 mg . each depocyte dose will depend on your baby
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare cases of adverse events have been observed with depocytes . depocyte may be administered with other chemotherapeutic agents . very common : may affect more than1 user in 100 nausea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after storage at room temperature , depocyte may be stored for up to 4 weeks at protected temperature . do this if you notice that the liquid is discolouration or a changed appearance . if you have a defective container , depocytes should be discarded .
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabiline . each 5 ml vial contains 50 mg cytabine ( as besilate ). - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as a 5 ml glass vial . it may be available as a single injection or
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacateol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to the group of medications called corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in the smaller airways , making breathing problems less likely . cortics reduce
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to peanut or soya . - if your doctor has told you that you have heart problems . - that you develop an irregular or fast heartbeat . - have thyroid gland problems . â if you have diabetes , high blood sugar , seizures or low level of potassium in your blood . â have severe liver problems . tell your doctor if you know that you are suffering from tuberculosis ( tb ) of the lung
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should inhale the medicine at the same time each day . this will help you to remember to use it . it is important that you use the medicine every day , as long as your asthma is being controlled . if your symptoms do not improve after using bemrid breez inhaler , contact your doctor . how bemist breezer is used bemrim breezhhaler comes as an inhaler and capsules
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very rare ( may affects more than one in 10 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do away with the capsules after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ), mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single dose contains 173 microgram indacate . each capsule contains 150 microgram of indacatedol and 80 microgrammometason furoATE . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microg / 62. 5 microlitre . each dose ( drip ) contains 150 milligrams of indiacater
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events ( such as stroke , heart attack , or
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking this medicine . warnings , precautions and precautions talk to the doctor or nurse before taking any of your zyllts : if you think
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zylltic contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllts
lamivudine teva contains the active substance lamivudrine . lamivudaine tevas is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine precludes the ability of the liver to repair damaged damaged cells and is therefore used for compensated liver disease
do not take lamivudine teva - if you are allergic to lamivu or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuvudine tea and other similar medicines can cause serious side effects , including liver disease , hepatitis c . if you become overweight , your doctor may need to change your dose . your doctor will do blood tests before you start your medication ( see section 4 " warnings and risks "). if you take lamvudine more often than you should if you have taken more lamivuzine tevas than you have been told to , tell
always take this medicine exactly as your doctor has told you . check with your doctor lamivudine teva is for oral use . swallow the tablets whole with a glass of water . you can take lamivodine tevas with or without food . your doctor will tell you how many tablets to take . if you have your hepatitis b infection , your doctor may decide to treat your infection at a lower dose . if your illness remains largely unchanged , you should continue taking lamividine tella for as long as your doctors prescribe it . if lamivudaine tev is not used in your kidneys , your dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy with lamvudine are : very common side effects that have been observed during lamivuine clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes . these are seen as signs of an increase in enzymes in the muscles . allergic reaction ( rare , may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivUDine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivodine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed with " 32
nespo is an anti - anaemic ( means that it does not affect your anaemia ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms are fatigue , weakness and shortness of breath . nespo works by inhibiting the natural hormone erythropoietin . erythroietin works by blocking the production of erythrombocytes , which are important for the kidneys . it also prevents your bone marrow from producing enough redblood cells . darbepoetin alfa is used to treat chronic renal failure . symptomatic anaemia is caused by chronic renal
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nesp ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor before using nespos if you suffer from high bloodpressure or are using medicines for sickle cell anaemia . if your child has epileptic fits ( seizures ), convulsions or fits . if he has liver disease . if any of the above applies to you , tell your doctor . if using drugs for anaemia , tell the doctor . an allergy to latex may occur
your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours . the pre - filled syringe is for injection into a vein . patients with chronic renal failure the usual dose is a single injection ( injection under the skin ) into a veins ( intravenous ). your doctor may decide to increase your dosage if your anaemia is not controlled enough . your dose of nespos will be calculated based on your body weight . the dose may be adjusted by
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 1 in 10 people ) uncommon ( may effect up to 1 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may affects up to1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare : ( might affect up to one in 10 , 000 users ) serious allergic reactions sudden life - threatening allergic reactions
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . before you start using nespen , your syringe may be stored at room temperature ( up to 30 ) for a maximum of 7 days . do this at the end of this 7 - day period . do away with nesp after this 7
what nespo contains the active substance is darbepoetin alfa . each ml of solution is a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 ml of the active substances darbasic and alfa - 2b . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nesp is a
macugen is a solution for injection into the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . in this disease , vision loss occurs due to damage to a part of the retina called the macula . macula is the thin layer between the two layers of the eye , the macular , and the eye ( amd ). abnormal blood vessels grow in the retina and the maculula . these new blood structures bleed and leak fluid causing the maculas to bulge , distorting or destroying central vision
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in theeye , stop macugen injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if the following symptoms occur , contact your eye doctor immediately : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to light small particles
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into the eye . the recommended dose is 6 to 9 injections per day . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen is given in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic (umbing medicine ) to prevent any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor may decide to temporarily stop antibiotic treatment for a short time to prevent eye
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe
palifermin contains the active substance escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract and in the tissues of the skin . palififermin is used to treat oral mucositis ( soreness or dryness ) associated with inflammation of the mouth , a common side effect that occurs during treatments for your blood cancer . if your bloodcancer is not well controlled with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a procedure that removes blood cells from the body ) it may be more likely that you will have side
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . children and adolescents kepivalance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepvelance tell your doctor if you take , have recently taken or might take any other medicines . in particular , tell your pharmacist if you have recently been given heparin . pregnancy and breast - feeding kepiva is not
how kepivance is given your doctor will decide on the dose you will receive . your doctor or nurse will decide the dose of cancer treatment . the recommended dose of kepvance is 60 mg . your dose of kpivant will be given to you by your doctor , nurse or pharmacist . the usual dose is one kilogram ( kg ) of body weight given as an intravenous injection into a vein . how kepvelance is administered kepervance is usually given to your child on three days of chemotherapy ( chemotherapy and radiotherapy ) followed by three days chemotherapy ( radiotherapy ). the first dose
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and increased levels of digestive enzymes in the blood . the frequency of these effects
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepivanance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , near the thyroid gland . cinaconalcate accordphara is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who are not on dialysis or who are unable to swallow food because they are not able to swallow it . to reduce the amount of calcium in the bloodstream ( hypercalcaemia ),
do not take cinacalcet accordpharma - if you are allergic to cinacealcep or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels regularly while you are taking cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cincacal cet accordPHarma : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken with or shortly after meals . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual dose of cinacealcut accordphara is 30 mg once a day ( one tablet in the morning and one tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . these side effects may be common ( might affect up to 1 in every 10 people ). dizziness , numbness
what cinacalcet accordpharma contains - the active substance is cinacealcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconalcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack cin
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformrin belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflo
do not take jentadueto : if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function . if you suffer from uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . this could lead to lactic acidosis ( see section " risk of lacticacidosis " below ). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets of linagliptin or metformrin , do not take this medication and continue to take this other medicine . if this medicine is not suitable for you , you may experience an upset stomach . the recommended dose is one 5 mg linaglptin tablet once a day with or just after food . your doctor may prescribe a lower dose of 2 , 000 mg metformina hydrochloride
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypoemia ). the frequency is common ( may affect up to 1 in 10 people ). the most serious side effect of jentadoueto plus sulphonylurea is related to the combination jentadauetoplus
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochloric acid . eachjentaduceto 2. 5 mg and 1 , 000 mg film film - coating contains 2. 25 mg of linaglptin and 1, 000 mg metin hydroxychloric Acid . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica ,
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants does not cure hiv . it is used in combination with hiv medicine in adults and adolescents aged 12 and older infected by hiv and who have not taken hiv before . your doctor will discuss with you whether edurent is suitable for you . if you have any further questions
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurants if you : are taking any of any of , or have recently taken any of : any of these : - the following medicines : carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines used to treat epilepsy and prevent seizures ) - rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . adults ( 18 years of age and older ) edurant should not be taken with food . do not take more than the recommended dosage . do this if you have any questions about how edurants works or why this medicine has been prescribed for you . talk to your doctor if you think any of these apply to you . edurent contains rifabutin . if you take more edurutant than you should if you accidentally take too
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpiviraine hydro chloride equivalent to 25 mg rilpeline . the other ingredients are : the film - coating : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film coating : the tablet core contains lactosemonohydrate , hypromellose 2910 ( e464
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin . rosigllitazONE and met formin work together by helping the insulin work better . this helps your body make better use of their blood sugars . avandamter is also used as a sulphonylurea ( a type of diabetes medicine ) in adults and adolescents .
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor will decide how much avandamet you need and for how long . if you have any questions about your diabetes , ask your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before taking avandamanet if : you have had a heart attack or severe angina you have heart failure you have ever had heart failure in the past you have severe breathing difficulties you have liver disease you have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved gradually over 1 to 8 weeks . the maximum dose is 4 mg rosciglitrazone ( corresponding to 1000mg metformatin ). thisdose is achieved slowly over 1 or 8 weeks , unless your doctor tells you otherwise . your doctor may increase your dose to the maximum dosage of 4 mg of rosigslitazrone ( equivalent
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamand and seek medical advice straight away . lactic acidosis ( a build - up of lactic acids in the blood ( lacticacidosis ) is a common side effect of metformin in patients with severe kidney disease . symptoms of lact acidosis include rapid
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister or the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths : 1 tablet of rosIGlitazon 500 mg metforman , 2 tablets of rosaiglitrazone 500 mg of metforma , 2 tablet of orosig litazone 1000 mg met formin , 4 tablets of o rosigllitazione 1000 mg of meetformin the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , povidone ,
clopidogrel mylan contains clopidogen and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before takingclopidigrel myl : if you think you may be at increased risk of bleeding ( such as - a medicalcondition that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopidaogrel melan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 . what
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thromboocytopenia ), in adults , in a medical procedure to stop bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have blood clots in the veins or arteries . warnings and precautions talk to your doctor or pharmacist before using doptelelet : - if any of these apply to you ( or you are not sure ), talk to the doctor or nurse before using this medicine . - if : you have recently had surgery or if you have been injured 23 - if the contraceptive birth control pill or hormone replacement therapy has not worked well enough -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is 5 mg once a day . your doctor may increase your dose to 8 mg once daily depending on your response to doptelet . your dose of dopteol may be increased to 20 mg once or 40 mg once every day . if you weigh 60 kg or more , your doctor will increase your daily dose to 5 mg ( once a daily ) once a week depending on the severity of your platelet counts . if necessary , your physician may increase the dose of this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles of the heart . rapiscan is used for the purpose of performing a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken using a thin needle to scan the muscles in the heart using a readmill . a scan is taken to measure the amount of a small amount of radiopharma in the body . this medicine is injected into a vein ( usually by
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease ( when a pacemaker is not working well ), chest pain ( unstable angina ), or treatment of low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if you : have a recent serious heart problem , have had a heart attack , have abnormal heart rhythms ( a heart rhythm where the heartbeat is very fast or uneven , atrial flutter
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over the same period of 5 minutes . if you are given a radioactive substance ( radiopharmaceutical ), the dose of rapiscan is
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection or up to 30 days after receiving any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . if you have any of these , tell your physician immediately . if any of them
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not taken any of these medicines , please contact your doctor . - if your doctor has prescribed nitric oxide donors such as amyl nitrite , which can lead to an increased risk of a dangerous drop in yourblood pressure . - when taking riociguat .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are not suitable for use in children . viag orodispersible tablets are for oral use . swallow the tablets whole with a glass of water . do not crush or chew the tablets . viaga can be taken with or without food . taking viagra with food will help you to get an erection . if you feel sexually stimulated , you should continue taking viaga until your sexual desire is satisfied . if your sexual interest is satisfied ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been seen with viagra . if you get any of the following side effects stop taking viagra and seek medical help straight away : - an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . - chest pains . - get in a semi - sitting position and use nitrates to relieve your chest pain . - prolonged and sometimes painful erections ( may occur rarely , may affect upt
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults , adolescents and children aged 12 years and older . it is used in combination with levodopa to treat parkinson '. sifroll is used for the symptoms in moderate to severe primary restless legs syndrome in adults .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifroll . - if your doctor has told you that you have any medical conditions that could increase symptoms of kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may increase the risk of dysk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , take 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg / day 1 ). after this , take one tablet of the 0 .088 mg / 0 . 270 mg tablet of each day . if your symptoms return , you may take two tablets of tablets of 1 tablet each day , with or without food . you can take sifol 0 . 0888 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) uncommon ( may affects up to1 in 1 , 000 people ) rare ( may effect up to one in 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , tell your doctor or nurse straight away if you notice any of the following side effects : - dyskinesia ( e . g .
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg of pramipxole as 0 . 125 mg , either 0 . 25 mg or 0. 5 mg of 1 mg prampipexol dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 . 019 mg tablets are white
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur when the body has a natural reaction to some materials ( allergens ). allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old and contains benzalkonium chloride . warnings and precautions talk to your doctor or pharmacist before using emadin . children and adolescents do not give this medicine to children under the age of 6 . clinical trials have not been performed in children and adolescent under the ages of 18 years . there is no experience with the use of emadino in children under this age group . if you have kidney or liver problems , talk to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults ( 12 years of age and older ) use in the same eye as adults . use this tip only once a day . do not use this if your eyes are not clear . children and teenagers use in infants ( 12 to 17 years of old ) use the same dose twice a week ( morning , evening and evening ) as adults ( 18 to 17 months of age
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate and will generally disappear after a few weeks . the drops should be used every day . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine in 0 . 5 ml solution . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). levestiracetamer has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported in patients treated with anti - epileptics . levetaracetam actsavis may cause thoughts of harming or killing themselves . tell your family or close friend if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis twice a day in the morning and once in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet once a day ( 1 , 000 mg ) for 3 weeks . your doctor will tell you the dose of levevetiratam acta to take . in adults , the recommended starting dose is 2 tablets once a morning ( 1, 000 mg ). after therapy dose in adolescents from 17
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests ( increase in a type of white blood cell ) 56 ( eosinoph
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each tablet contains 250 mg of levetoracetam ( as levetmiracetam ). leveturacetam actingavis 500 mg : one tablet contains 500 mg of the active ingredient levetiroacetam. levetvetiratam activ 750 mg : the active substances are levetieracetam and water for injections . leveriracetaman actavis 1 , 000 mg : every tablet contains 1 , 500 mg levetirusacetam the other ingredients are
celemidinium bromide belongs to a group of medicines called bronchodilators . incruse ellipta contains the active substance umeclidinum bromides which belongs to the group of bronchiolators that are used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become damaged . this can lead to breathing difficulties . incrose elliptea helps to control difficulties in breathing by tightening the muscles around the airway . this medicine prevents tightening of these muscles in the air passages in the lung , making it
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruere ellipta should not be used in asthma patients . talk to a doctor or nurse before using incrusey ellipta if you : have heart problems have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ) have severe liver problems have immediate breathing difficulties such as
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use incruse ellipta more than once a week . if you use more incrupe ellipta than you should if you have used more incrose elliptas than you have been told to use , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead these may indicate inflammation of the sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalER should be used within 6 months . once the tray has been opened , the seal should be replaced . do away with the inhalizer and allow the inhalera to reach room temperature (
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramrams umelidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incruere ellipta is an inhalation powder . the ellipta inhaler consists of a grey plastic body , a light green mouthpiece cover
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs breathe ) in patients with eosinaophilic asthma . what nucalo is used for asthma nucalan is used in adults to prevent asthma attacks when you are already taking medicines called high dose inhalers . it helps control your asthma by helping you breathe more easily . these medicines can be
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to treat your asthma with nucal . if your asthma does not respond to nucalan , your physician may decide not to continue nucalo treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) can cause
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a day . the recommended starting dose is 1 mg once daily . you should use the pre - filled pen at the same time each day . how much nucala to use your doctor will decide how much treatment you need . how long to use nucal will depend on how you respond to the treatment . your doctor may decide to change the dose of nucale depending on your asthma symptoms and attacks . if your asthma symptom is not controlled with injections , your doctor can
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms can be severe . symptoms can include chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to a similar reaction that you had with n
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucal pre - filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 3 8 ). discard the pen after 7 days . do away with the pre - fill pen if it has been frozen . do throw away any medicines via
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a pack containing 1 ampoules or as a multipack containing 3 ampouls or 1 ampule . not all pack sizes may be
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it works by blocking a lot of proteins called proteasomes . what it does for your child ' s body : what ninlalo is used in adults and children with multiple myelooma , ninlAR is used alone or in combination with lenalid
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions : bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash . liver or kidney problems . your doctor may decide to reduce the dose of treatment with ninlara or stop treatment . your blood tests will be taken to check that you have enough blood cells
you must not be given ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlar is lenalidomide ( a medicine that dissolves rapidly in the body ), and dexamethasone ( an anti - inflammatory medicine ). the recommended starting dose of each dose of the ninlara combination of lenalidomeide and dexamanethasONE is 4 - week . you will take one dose of one dose ( 0 . 5 ml ) of nin
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the entire body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , sometimes with red to purple
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do this medicine if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib and 3 . 3mg ixabomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the capsule content contains gelatin, titanium dioxide , blackiron oxide [ ed172 ], shellac and propyleneglycol , sodium
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfourzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because peanut ( desensitisation ) is not a natural reaction to peanut . palfiorzia is not intended to cause allergic reactions . pafforzinia is not for use in children and young people with food allergies . talk to a doctor or nurse before using this medicine if you have any questions about how palforbzia
do not take palforzia if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if this happens to you , tell your doctor and do not take the next dose until 60 days after stopping treatment with your palferzia . warnings and precautions talk to your doctor or pharmacist before taking palfORzia : if you notice any of the symptoms above , talk to the doctor .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will determine the dose you need and will determine if you need to be treated for allergy . allergic reactions ( anaphylaxis ) are usually mild to moderate and usually disappear within 3 months of starting treatment with palforzia . initial doseescalation is usually initiated during the first week of these treatment steps . the initial dose escalation and up - dosing steps should be repeated every three weeks . if you take more palfourzia than you should if you have taken more pf
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you have any of the following symptoms , stop taking palforfzia and seek medical help immediately : - the reaction may include trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palforsia may cause problems with the stomach and digestive system ( eos
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforzinia . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallrine cellulose ( e460 ), colloidal anahydrous siliconica and and magnesium unstearate ppalforza 300 mg oralpowder in sachet microcry crystalline celluloses ( e464 ), colloid anhydrated silica , and
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used in adults , adolescents and children aged one month and older . treatment is started at the start of the treatment and should be continued until you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ). children and adolescents do not give this medicine to children and teenagers under 18 years of age because it has not been studied in this age group . if you take more zeren than you should if you think you have taken too much
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , you should take the capsule at bedtime . if your doctor tells you to take zerne , you may take it at bed time . if the dose is too low , you can take it again at bedside . if it is not , you could take it with or without food . if there is no food or drink available , you must take zera at bedtimes . if this happens , you will take
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) uncommon : 1 to10 users in 1 , 000 very rare ( affects less than 1 users in 10 , 000 ) very rare : very rare , affects lessthan 1 user of 10 ,000 not known ( frequency cannot be estimated from the available data ) very common : may affect more than1
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - the printing ink contains gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide , ( s - 13050 ). - printing ink containing shellac
